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The skin is the largest organ of the human body. One of its main functions is to protect against 
pathogens and ultraviolet light (UV). The following layers can be identified in the skin: the 
epidermis, dermis, and underlying subcutis (Figure 1). In the epidermis, several layers can be 
distinguished. From the outside to the inside: the stratum corneum (SC), stratum granulosum 
(SG), stratum spinosum (SG) and stratum basale (SB). Keratinocytes represent the major cell 
type in the epidermis. They develop in the basal layer of the epidermis and differentiate while 
migrating upwards. They are designed to constantly renew the skin, which is important in skin 
wounding. Other cells in the epidermis include melanocytes and Langerhans cells.1,2 The dermis 
consists of connective tissue protecting the epidermis and the vascular and nervous plexuses 
running through it. Furthermore, it contains few inflammatory cells that regulate inflammatory 
responses. The subcutis is the fat layer below the dermis and mainly consist of adipocytes. This 
layer plays an important role in thermoregulation and also functions as a shock absorber.2
Figure 1. Clinical image and histological hematoxylin-eosin stained tissue section of normal skin.
(Reprinted from the thesis of M. Peppelman).3
Due to its visibility and accessibility, the skin is easy to examine. Therefore, in dermatology, 
morphological characterisation of the skin is important in diagnosing and monitoring of treatment 
effects. Dermoscopy is a non-invasive method that allows evaluation of skin lesions using a tenfold 
magnification. Dermoscopy has been implemented in clinical dermatology, mainly in the field of 
dermato-oncology, using standardised pattern algorithms.4,5 Despite its advantage, histological 
confirmation is often necessary to secure the diagnosis. However, histological confirmation, by 
obtaining a punch biopsy, is an invasive method. In addition, only part of the lesion can be 
examined and therefore sampling error may occur. In recent years, various advanced imaging 
techniques have been developed that reveal more detailed morphological features of the skin 
non-invasively. These techniques may be used as diagnostic and monitoring tools and evade 
the need for a skin biopsy. Reflectance confocal microscopy (RCM) and videodermoscopy (VD) 
are examples of these techniques. 
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For RCM, there is increasing evidence for its applicability in melanocytic lesions.6-10 However, less 
is known about the role of RCM in non-melanoma skin cancer (NMSC), especially in squamous 
cell carcinoma (SCC) and its precursor lesions.11-18 Also, (video)dermoscopy is mainly used 
in neoplastic skin lesions.4,5,19-27 However, less is known about its value in inflammatory skin 
diseases (ISD).28-31 Moreover, there is scarce knowledge on the possible additional value of VD, 
compared to dermoscopy, in this area.32-34 Therefore, this thesis will focus on the diagnostic 
and monitoring values of RCM in NMSC and (video)dermoscopy in ISD in order to optimise the 
current diagnostic techniques, such as histological examination. 
1.2 Non-melanoma skin cancer 
In the Caucasian population, skin cancer is the most common type of cancer with rising 
incidence rates worldwide.35,36 Skin malignancies can be divided into two main categories that 
encompasses melanoma and NMSC, that represent approximately 10% and 90% of the skin 
malignancies, respectively.37,38 The term NMSC is mostly used to define basal cell carcinoma 
(BCC) and squamous cell carcinoma (SCC).39 The incidence ratio between SCC and BCC is 
approximately 1:4.35,40 Risk factors for developing BCC and SCC include individuals with fair 
skin, actinic damaged skin, exposure to ultraviolet radiation, chronic use of immunosuppressive 
medication, exposure to carcinogens (e.g. psoralens, arsenic, ionizing radiation), presence of 
chronic ulcers or burn scars, or genetic syndromes.39 The majority of patients with a skin cancer 
are prone to develop skin cancer again.41 About one-third of all patients who had a first BCC 
will develop at least a second BCC and in some cases a SCC.42 These elevated risks vary 
geographically and reflect the underlying incidence rates.42
1.2.1 Basal cell carcinoma
Though, there is no consensus yet about the precise aetiology, BCCs are most likely to 
arrive from stem cells within hair follicles and interfollicular epidermis.43,44 There are different 
histological subtypes (superficial, nodular, micronodular and infiltrative).45 Each subtype has its 
own biological behaviour that affects treatment options and likelihood of tumour recurrence.46 
Most BCCs occur in the head and neck area, followed by trunk and extremities.47,48
Clinical features
Nodular BCC (nBCC) is the most common subtype, accounting for 50-79% of all BCCs.47,49 These 
lesions are characterised by nodules with a pearly shine and small arborizing teleangiectasias. A 
crust may appear over a central depression and the lesion may ulcerate over time. Micronodular 
BCCs manifests as plaque-like indurated lesions with a poorly demarcated contour and have 
a higher incidence of local recurrence.50 Superficial BCC (sBCC) is the second most common 
subtype, accounting for up to 15% of all BCCs.47 They typically appear as well-described, 
scaly, pink-to-red maculae, thin papules or plaques. Infiltrative BCC (iBCC) occurs less often, 
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accounting for 5-10% of all BCCs.47 Lesions present as pink-to-ivory, shiny, smooth, scar-like, 
indurated plaques or depressions with ill-defined borders. 
Histopathology 
Basal cell carcinoma can be divided into two main groups: non-aggressive growth subtypes 
(superficial and nodular) and aggressive growth subtypes (micronodular and infiltrative). 
Aggressive subtypes are more likely to recur and tend to cause extensive local destruction. 
When a BCC consist of more than one histological subtype, they are called a mixed type BCC. 
The incidence of mixed type BCCs ranges from 19% to 74%.51-54 Basal cell carcinomas are 
histologically characterised by aggregations of basaloid keratinocytes with, at times, peripheral 
palisiding of nuclei (Figure 2). Often, the basaloid aggregations are surrounded by stromal 
tissue and regularly there is a microscopically visible cleft present between the tumour nests and 
peritumoural stroma. Nodular BCC is characterised by large, round to oval, nests of basaloid 
cells in the papillary or reticular dermis with peripheral palisiding and peritumoural clefts.45 
Ulceration may be present and cystic spaces within larger tumour islands due to necrosis. Like 
nBCC, micronodular BCC (mnBCC) show round or oval tumour nests but are smaller. They 
are approximately the size of hair bulbs and are more widely dispersed, and extending deeper 
into the dermis.55 In some cases, these nests can penetrate the subcutis. Superficial BCCs 
are characterised by nests of basaloid cells residing high in the dermis, usually in a multifocal 
pattern.45 Infiltrative BCCs consist of irregular, non-rounded strands or nests of basaloid cells 
surrounded by peritumoural stroma.45 Sometimes the basaloid nests even penetrate the 
subcutis. Peritumoural clefting is uncommon and there is no peripheral palisiding. 
Treatment 
Basal cell carcinoma has a very low potential to metastasize. However, there might be 
considerable functional and cosmetic morbidity due to localised tissue invasion and therefore 
adequate treatment is necessary.35,39,56 Various treatment options for BCC are available and 
depend on the histological BCC subtype. The treatment option of mixed type BCCs depends on 
the most aggressive BCC subtype. Surgical excision can be used to treat all BCC subtypes and 
is generally considered to have the lowest failure rate.57 According to the Dutch guidelines, the 
advised excision margin for low risk BCCs (nBCC and sBCC) < 10 mm in diameter is 3 mm. For 
high-risk BCCs (iBCC, mnBCC  or recurrences) and/or tumours larger than 10 mm, the advised 
margin is 5 mm.58 Non-surgical treatments include photodynamic therapy (PDT), 5-Fluorouracil 
(5-FU) cream and Imiquimod cream, and are mainly used to treat sBCCs. These treatment 
options are non-invasive and usually result in better cosmetic outcomes compared to surgical 
excision.59,60 Furthermore, in some cases radiotherapy can be performed, mainly for high-risk 
tumours in patients who are unwilling or unable to tolerate surgery.61 
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1.2.2 Squamous cell carcinoma and its precursors 
Squamous cell carcinoma can arise from precursor lesions such as actinic keratosis (AK), 
actinic cheilitis (AC), and squamous cell carcinoma in situ (Bowen’s disease and erythroplasia 
of Queyrat).39 While AK develops in the skin, AC arises on the lips.62 Bowen’s disease (BD) is 
an in situ SCC of the skin, while in erythroplasia of Queyrat (EoQ) the penile glans or prepuce 
are commonly involved.63 Keratoacanthoma (KA) is another cutaneous neoplasm that clinically 
and histologically resembles a SCC. There is controversy about whether KA is a separate entity 
or a subtype of SCC (low-grade SCC).64 According to various studies the estimated rate of 
progression of AK to SCC is up to 20%.65,66 However, it was also concluded that reliable estimates 
of malignant transformation of AK could not be derived from existing data, especially due to the 
lack of reliable means of monitoring AKs over time.  
Clinical features
Actinic keratosis usually appear as scaly, skin coloured, pink or brown superficial papules or 
plaques, often with an erythematous base (Figure 2).38 Actinic cheilitis manifests as an atrophic 
white papule or plaque that usually becomes fissured, eroded, or ulcerated.38 Bowen’s disease 
usually presents as an erythematous, well-demarcated, scaly plaque.38 Erythroplasia of Queyrat 
appears as a well-demarcated, flat, non-infiltrated eythematous plaque with no tendency of 
spontaneous regression.67 Well-differentiated SCCs are classically recognised by thick, scaly 
papules and plaques, whereas poorly differentiated SCCs are often soft, non-scaly, ulcerated 
or hemorrhagic.38 Keratoacanthoma presents as a dome-or bud-shaped, well-demarcated, 
umbilicated nodule with a hyperkeratotic plug in the centre. It evolves in 3 clinical stages: 
proliferative, mature, and resolving.68 
Histopathology 
Actinic keratosis is characterised by keratinocyte dysplasia with aggregates of atypical, 
pleomorphic keratinocytes with nuclear atypia, dyskeratosis, and loss of polarity. It can be 
classified according to the Keratinocyte Intraepithelial Neoplasia (KIN) system, with subdivision 
into three histological grades.69-71 In AK KIN I, the keratinocytic atypia involves only the lower 
third of the epidermis. In AK KIN II, the atypical cells affects the lower two-thirds of the epidermis. 
In AK KIN III, including BD, the full epidermis is affected without infiltration of atypical cells 
into the dermis. Furthermore, hyperkeratosis, parakeratosis and solar elastosis in the dermis 
are often seen.71 Squamous cell carcinoma has similar histological features as AK, but can 
be distinguished from AK due to the presence of tumour cells passing through the basement 
membrane into the dermis. Furthermore, nests of atypical tumour cells are formed in the dermis. 
Usually, there is full thickness epidermal atypia and a dermal inflammatory infiltrate.71 Cellular 
characteristics of KA are similar to those of SCC.68 
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Figure 2. Clinical images of (pre)malignant skin lesions (1) with their corresponding hematoxylin-eosin 
stained tissue sections (2). A) Nodular basal cell carcinoma. B) Superficial basal cell carcinoma. C) Actinic 
keratosis. D) Squamous cell carcinoma.




In a small number of cases, SCC might be life-threatening as it has the ability to metastasize. 
Therefore, adequate treatment is important. Surgical excision or radiation therapy are the 
preferred treatment for SCC.38 Furthermore, treatment of the precursor lesions is recommended, 
as it is not possible to predict which of the precancerous lesions will progress into a SCC. 
The most common applied treatment for AK is liquid nitrogen cryotherapie. More extensive or 
multiple AK can be treated with 5-FU cream, Imiquimod cream and PDT. Other therapies for 
AK include Ingenolmebutaat or Diclofenac 3% gel.72,73 Most of these treatments can also used 
to treat AC.62 Treatment options for BD and EoQ include e.g. liquid nitrogen cryotherapie, PDT, 
5-FU, Imiquimod cream and surgical excision.74 For KA, surgical excision is the first choice of 
treatment.68
1.3 Inflammatory skin diseases
The term ISD encompasses a broad range of diseases in which inflammatory processes play 
an important role. Inflammation can be defined as a complex defence mechanism of the body 
to dangerous endogenous or exogenous stimuli. An overview of various ISD is described in the 
textbook of Billings et al.75 The clinical classical signs of inflammation are rubor (redness), calor 
(heat), dolor (pain), tumour (swelling), and function laesa (disturbed function). Treatment options 
may vary from topical to systemic therapy. Since many cell types and mechanisms are involved 
in ISD, it is challenging to unravel the pathogenesis. Therefore, in histopathology, morphologic 
criteria are used for classification. 
Histopathology 
In general, most inflammatory dermatoses can be divided into two categories: epidermal 
and dermal patterns.76 In the epidermal patterns, there are 3 primary patterns (spongiotic, 
psoriasiform, and interface). The spongiotic pattern is characterised by intra-epidermal 
accumulation of oedema. Psoriasiform patterns are identified by epidermal hyperplasie, 
whereas the interface pattern is recognised by damage to the basal layer of the epidermis by 
an inflammatory infiltrate. The dermal patterns lack significant epidermal changes. Broadly, the 
dermal patterns can be divided into 4 patterns (perivascular, nodular and diffuse, palisiding 
granulomatous and sclerosing). The perivasculair pattern shows an inflammatory infiltrate 
mainly around dermal blood vessels in a superficial, or superficial and deep distribution. In the 
nodular and diffuse pattern, the infiltrate is less concentrated around the blood vessels. The 
palisiding granulomatous pattern is characterised by infiltrates surrounding zones of altered 
collagen. In sclerosing dermatoses, fibrosis of the dermis is present, usually with relatively 
little inflammation. Even though most ISD can be sorted into one of the major categories, there 
are inevitable dermatitides that defy classification or show overlapping features.76 In addition, 
a particular dermatitis may have a completely different appearance early in the course of the 
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disease compared to late in the disease process. Therefore, some inflammatory lesions may 
be sampled either too early or too late in their evolution to be diagnostic. This dynamic process 
of inflammation results in lesions that are heterogeneous. Therefore, it is critical to sample the 
appropriate site with knowledge of the point in time when the lesion was sampled, to detect 
morphological changes that are optimal for microscopic interpretation and diagnosis.77
1.4 Limitations of histopathological evaluation 
In dermatology, the majority of skin lesions are diagnosed clinically after visual inspection of the 
skin. Sometimes a dermoscopy is used to aid in the clinical diagnosis. In case of suspicion of 
NMSC or clinical difficult to diagnose ISD, a diagnostic punch biopsy may be obtained. However, 
punch biopsies are invasive diagnostic methods which may result in scarring, inflammation, 
hindering the ability to monitor the dynamic processes over time and the number of biopsies 
is limited due to practical and cosmetic reasons. Furthermore, it may be a challenge to select 
the appropriate biopsy site to sample, particularly in heterogeneous lesions. There is a risk of 
sampling error, in which the biopsy was not taken from the most aggressive or active part of 
the lesion and therefore the diagnosis is missed.52,53,78-80 As a result, e.g. the aggressive BCC 
subtype or the presence of a SCC in a large AK lesion may be missed. In addition, due to the 
heterogeneity of an inflammatory lesion in ISD, it can be challenging to choose an appropriate 
site for sampling. This can lead to non-specific and descriptive diagnoses, making it difficult 
to select an adequate treatment. Moreover, when a punch biopsy is obtained, only a part of 
the punch biopsy will be histopathologically evaluated. Theoretically, the most aggressive or 
active part of the punch biopsy may be missed resulting in under- or misdiagnosis. This may 
lead to patient discomfort and high treatment costs due to subsequent treatments. Therefore, 
it is interesting to evaluate the sampling error within a punch biopsy. In addition, the usage of 
advanced imaging techniques may play a role in reducing the risk of sampling errors.
1.5 Advanced non-invasive imaging techniques
1.5.1 Reflectance confocal microscopy
In 1957, Marvin Minsky invented the confocal microscope.81,82 During that time, the microscope 
was only suitable for imaging of ex vivo tissue samples. Thereafter, changes were made enabling 
in vivo imaging of human skin. Currently, the most frequently used in vivo RCM devices in the 
field of dermatology are the Vivascope 1500 and 3000 (handheld device) by Caliber Imaging 




Figure 3. Vivascope 1500 device. 
A metal ring with an adhesive window is placed onto the skin. A drop of fluid is applied between the window 
and the skin. The VivaCam is used to obtain a clinical dermatoscopic image. Afterwards, ultrasound gel is 
placed onto the window and the objective lens housing is attached to the metal ring. After starting the laser, 
images in black and white will appear on the computer screen.
(Reprinted from the thesis of M. Peppelman).3
Technical principle 
The reflectance confocal microscopy uses a point source of light, derived from a near-infrared 
830 nm laser83, which penetrates into the skin and illuminates a small point inside the tissue 
(Figure 4). The laser power lies between 5 and 10 mW and does not cause any damage to 
the skin. Structures within the skin reflect the laser light. Subsequently, a detector collects the 
reflected light through a small pinhole and out of focus light from another tissue point will be 
blocked from detection. Therefore, only reflected light from the focal region is detected. The 
lateral resolution of RCM is less than 1.25 µm and the axial resolution is less than 5 µm. This 
technique produces images of the skin parallel to the skin surface (en face) and can examine 
the skin up to a depth of approximately 250 µm. The contrast in RCM images relies on the 
differences in the reflectivity of tissues, which is depending on their chemical and molecular 
structures. Structures with a high refractive index, like melanin and melanosomes, appear 
bright in RCM (Figure 5). The reflectivity of white blood cells, chromatin, collagen and elastin is 
lower.84-88 In normal skin, RCM can visualize the epidermis, papillary dermis and superficial part 
of the reticular dermis. Each layer has its own set of distinct RCM features (Figure 5). A digital 
camera (VivaCam) is part of the Vivascope set up. Prior to RCM imaging, the VivaCam is used 
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to capture a clinical dermatoscopic image of the lesion. Afterwards, this clinical image can serve 
as a navigation map during RCM imaging.
Figure 4. Schematic illustration of the technical principle of the reflectance confocal microscopy.
(Reprinted from the thesis of M. Peppelman).3
Practical aspects
In order to obtain RCM images of a lesion, a metal ring with a polymer window is attached to the 
skin. This ring is magnetically connected to the objective lens housing to stabilize the imaging 
location. To reduce the amount of backscattering of light and to optimise image quality, a drop of 
water or oil is applied between the window and skin. In addition, ultrasound gel is placed between 
the window and objective lens housing. The standard acquired RCM image depicts an area of 
500 x 500 µm of the skin (confocal image) (Figure 6). The separate horizontal confocal images 
can be assembled into a large mosaic image of maximum 8 x 8 mm (VivaBlock). Moreover, the 
objective lens can move vertically to capture images in depth (VivaStack), while maintaining 
the same field of view. This VivaStack has an automatic section depth of 4.5 µm, but can be 
adapted to other preferable depths. In addition, videos at 9 frames per second can be captured 
to document dynamic processes (e.g. blood flow, and migration of leukocytes). 
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Figure 5. Histological tissue section of the normal skin (in vertical plane) with lines at the level of stratum 
corneum (SC), stratum granulosum (SG), stratum spinosum (SS), dermo-epidermal junction (DEJ) and 
dermis (D). At these levels, reflectance confocal microscopic (RCM) images are obtained (in horizontal 
plane). Each level has its own distinct RCM features. SC: grey, with no nuclei or cellular outlines. SS and SG) 
dark round nuclei with surrounding bright cytoplasm in a regular honeycomb pattern. DEJ) dermal papillae 
visible as dark circles. D) dark grey with reflective reticular fibers. Illustration depicts the reflectivity of cellular 
and subcellular structures of the skin decreasing in brightness. 
(Reprinted from the thesis of M. Peppelman).3




RCM allows in-depth imaging of the skin in a comfortable, non-invasive, manner without causing 
pain or scarring. The skin tissue is not altered by tissue processing (e.g. fixation, mounting) or 
staining. Real-time data collection is faster than routine histology and a whole lesion can be 
investigated. This might reduce the risk of sampling error and decrease delay in diagnosis and 
adequate treatment. Furthermore, the same location of the skin can be repeatedly imaged over 
time. This allows monitoring of a lesion to evaluate processes such as lesion progression or 
response to therapy. 
Melanin and melanosomes are key histological features of melanocytic lesions and are strong 
contrast sources for RCM imaging. Therefore, most research was focussed on melanocytic skin 
lesion at the time RCM was first introduced in the field of dermatology.6-10 Thereafter, studies on 
the application of RCM in NMSC appeared, mainly focussing on BCC and its subtypes.12,14,18,89-95 
Only a small number of research was performed on other types of (pre)malignant skin cancers 
in NMSC, namely SCC and its precursor lesions.13,80,89,96 In addition, the role of RCM in ISD has 
been studied.97-101
Figure 6. Reflectance confocal microscopic images. 
A) Confocal image: basic image of 500 µm x 500 µm. B) VivaStack: a sequence of confocal images (500 µm 
x 500 µm) captured at the same horizontal position but at different depths. C) VivaBlock: a mosaic of 8 x 8 
confocal images (4 mm x 4 mm) providing a larger field of view.
(Reprinted from the thesis of L. Hoogedoorn).102
1.5.2 (Video)dermoscopy 
In 1663, skin surface microscopy was first introduced by J.C. Kolhaus, who applied the method 
originally to inspect the nail fold capillaries.103 The term ‘dermatoscopy’ was first used in 1921 
by J. Saphier.104 The technique was further developed by Goldman in the 1950s and called 
‘dermoscopy’. He was the first dermatologist to use this new technique for the evaluation 
of pigmented skin lesions.105 Since then, many studies have been published on the use of 
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dermoscopy in pigmented skin lesion.106-111 Today, dermoscopy has become a routine practice 
in Europe and gaining acceptance in other countries.
Technical principle 
Dermoscopy (also known as surface microscopy or epiluminescent microscopy) is a technique 
that allows a rapid and magnified in vivo observation of the skin surface. By definition, it is 
performed with handheld devices (dermatoscopes), allowing 10x magnification (Figure 7). 
Conventional dermoscopy uses non-polarised light sources to illuminate the skin. It requires 
a liquid interface and direct contact between the scope and the skin. In this way, the amount 
of light reflected, refracted and diffracted at the skin surface is reduced, allowing the observer 
to visualize structures below the stratum corneum.112 Currently, also polarised dermatoscopes 
are available. Unlike non-polarised light dermoscopy (NPD), polarised light dermoscopy (PD), 
allows visualization of deep skin structures without the necessity of a liquid interface.113 
Figure 7. Dermatoscope.
Between 1980 and 2000, there were many improvements in digital camera and computer 
technology which have led to the development of the digital dermatoscopy (videodermatoscope).114 
Videodermoscopy (VD) is performed by a video camera equipped with optical fibers and lenses 
that allow high-resolution imaging at magnifications up to 1000x (Figure 8). The images obtained 
are visualised on a monitor and can directly be stored digitally, to identify and compare changes 
over time.115 To aid the dermatologist, some of the systems offer the possibility of computer-
assisted diagnosis for malignant melanoma or for consulting an expert through telemedicine.




Both dermoscopy and videodermoscopy are mainly used for the evaluation of pigmented skin 
tumours. Multiple algorithms have been developed to diagnose melanoma (e.g. ABCD rule, 
7-points checklist and Menzies method).83,111,116-119 On the other hand, they are also used in 
the area of ISD, in order to assist the clinical diagnosis and reduce the need for invasive skin 
biopsies.120-122 As videodermoscopy allows higher magnification, it may offer visualization of 
more specific features compared to dermoscopy. Therefore, it would be interesting to evaluate 
the current and future role of (video)dermoscopy in ISD and the possible benefit of VD over 
dermoscopy in this area.
Figure 8. Videodermatoscope.
The naevus on the arm is visualised on the computer screen of the videodermatoscope with a magnification 
of 80x. 
1.6 Aims and outline
At present, skin biopsies are the gold standard for diagnosing cutaneous malignancies and 
clinical difficult to diagnose ISD. However, a punch biopsy is prone to sampling errors. This 
may occur due to sampling an inappropriate site within a heterogeneous lesion or perhaps due 
to missing the most aggressive or active part within a punch biopsy during histopathological 




The overall objective of this thesis is to explore the morphology of the skin using advanced 
imaging techniques in order to optimise the current diagnostic process. The thesis primarily 
focuses on 3 aims:
 1. To investigate the sampling error in sBCC and its clinical effect 
 2. To investigate the applicability of in vivo RCM in NMSC
 3. To investigate the applicability of (video)dermoscopy in ISD
Chapter 2 focuses on sampling errors and its clinical effects in lesions diagnosed as sBCCs using 
punch biopsies. Chapter 2.1 evaluates whether more aggressive BCC subtypes can be detected 
with additional step sectioning in the histopathological examination procedure in punch biopsies, 
that were initially diagnosed as sBCCs. In chapter 2.2 the clinical efficacy of two different MAL-PDT 
protocols for the treatment of sBCC is studied. Interestingly, it evaluates whether treatment failures 
and recurrences are related to sampling error of the primary punch biopsies. 
The use of advanced imaging techniques, such as the RCM or (video)dermoscopy,  might be 
able to diminish the risk of sampling error. Therefore, these techniques are evaluated in chapter 
3 and 4. Using RCM, an in-depth exploration of the skin can be performed to detect the most 
affected area within a lesion. It may be used as a diagnostic tool and evade the need for a 
skin biopsy. However, prior to the use of RCM as a diagnostic tool, explorative studies have 
to be conducted to evaluate diagnostic RCM features for specific skin conditions. Therefore, 
in chapter 3.1 specific RCM features for skin entities within the continuum of AK and SCC 
are studied. Furthermore, chapter 3.2 addresses the study where specific RCM features, to 
differentiate between SCC and AK, are explored. In addition to AK and SCC, multiple explorative 
studies have already determined diagnostic RCM features for the diagnosis of BCC, including 
its subtypes, and features to differentiate it from other skin entities. Therefore, the regular use 
of RCM as a diagnostic tool for the diagnosis of BCC in daily clinical practice is getting closer. 
Nonetheless, a large RCT is necessary to investigate the cost-effectiveness and whether RCM 
is (non-) inferior to histopathological evaluation of punch biopsies, in diagnosing BCC and its 
subtype, prior to implementation in dermatological practice (chapter 3.3). 
The use of dermoscopy and VD offer clinicians the possibility to examine a greater area under 
a high magnification. Both techniques are mainly used within the pigmented dermato-oncology. 
However, they can also be useful in ISD, as these entities can occur in the facial region, where 
invasive skin biopsies are not cosmetically favoured. (Video)dermatoscopy may improve the 
diagnostic accuracy of a clinical diagnosis without the need for invasive skin biopsies. Though, 
prior to the use of (video)dermoscopy as a diagnostic tool, specific (video)dermoscopic features 
for different ISDs have to be determined (chapter 4.1). 
In chapter 5 the results presented in this thesis are summarised and discussed. 
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Background: Correct diagnosis of superficial basal cell carcinoma (sBCC) is essential due 
to the increase of non-surgical treatments for this subtype. Histological confirmation by punch 
biopsy for the diagnosis of BCC and its subtype is recommended. However, a standardised 
histological method for sectioning punch biopsies is currently missing. 
Objective: To compare the accuracy of histological examination of only one level in sBCC punch 
biopsies (current method) with a more extensive step-section method. Additionally, to investigate 
whether tumour thickness, ulceration and adnexal extension are determinants of treatment failure 
or recurrence in initial diagnosed sBCCs.
Methods and methods: 116 sBCC punch biopsies, obtained between 2014-2015 at the 
Department of Dermatology (Radboud university medical center, Nijmegen, the Netherlands), 
were cut in 4 additional levels and thereafter histopathologically evaluated. 
Results: In 22.4% a more aggressive BCC subtype was missed with the current examination 
process. In 25% of the treatment failure and recurrence group, sBCCs were thicker than 0.4 mm. 
Ulceration and adnexal extension did not occur in this group. 
Conclusion: This study shows that histological examination of only one level in a punch biopsy 
leads to underdiagnosis of more aggressive BCC subtypes in biopsies diagnosed as sBCC. 
Recommendations for a revised examination method are proposed to reduce the risk of missing 
more aggressive BCC subtypes and to prevent undertreatment.
 




Basal cell carcinoma (BCC) is the most common malignancy in the Caucasian population with 
a rise in incidence worldwide, emphasizing the importance of BCC diagnosis and managment.1 
European guidelines recommend a punch biopsy of clinically suspected BCC prior to treatment 
to confirm diagnosis and identify the histological subtype.2 There are different histological BCC 
subtypes, each with its own biological behaviour that affects the treatment options and likelihood 
of tumour recurrence.3 Aggressive BCC subtypes include infiltrative (iBCC) and micronodular 
(mnBCC) types that have a high risk of incomplete excision and recurrence. Nodular (nBCC) 
and superficial BCC (sBCC) are considered non-aggressive BCC subtypes.4 While nBCC is 
the most common histological subtype, a significant higher increase in the proportion of sBCC 
is noticed.5 The dramatic increase in sBCCs leads to a greater applicability of non-surgical 
treatment options such as methylaminolaevulinate photodynamic therapy (MAL-PDT) and topical 
application of Imiquimod and 5-Fluorouracil (5-FU).6,7 Mixed type BCCs consist of multiple 
subtypes. The treatment option of mixed type BCCs is dependent on the most aggressive BCC 
subtype. However, misdiagnosis of the subtypes within mixed type BCCs can occur due to a 
sampling error within the lesion. Multiple studies have evaluated the reliability of a punch biopsy 
in accurately subtyping BCCs by comparing the initial punch or shave biopsy with the excision 
specimen. The discordance ranged between 18.0% and 39.1%.8-11 However, to the best of our 
knowledge, no studies have analysed the sampling error within a single punch biopsy. Failure 
to detect aggressive subtypes by histopathological evaluation of a punch biopsy may result in 
undertreatment and eventually lead to more patient discomfort and higher healthcare costs. 
According to the Dutch guideline, the histopathological examination report of a BCC punch 
biopsy must include at least the lesion’s location, histological growth pattern and whether 
it is a recurrent BCC.12 However, the histological examination process of punch biopsies 
performed in lesions suspicious for BCC is not standardised. Therefore, there is a variation 
across institutions with respect to histopathological evaluation methods. At the Department of 
Pathology at the Radboud university medical center (Radboudumc), Nijmegen, the Netherlands, 
the current protocol for the histological examination of a 3 mm punch biopsy suspicious for 
BCC consists of evaluation of two to three, 4 µm thick, hematoxylin and eosin (H&E) stained 
tissue sections. These sections are obtained from one level, in which the contour of the punch 
biopsy is completely visible (at approximately 1000 µm). In case a BCC histological subtype is 
detected in the initial H&E sections obtained from the first level, no additional levels will be cut 
and the histopathological diagnosis will be based on the detected BCC subtype. When no BCC 
is identified in the initial H&E sections, the punch biopsy is cut at four more levels with an interval 
of approximately 200 µm. One to two H&E sections per level are analysed. In case a mixed 
subtype is found, the histopathological diagnosis will either be based upon all the detected BCC 
subtypes or only the most aggressive subtype that is of most relevance for treatment selection.
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There is a debate whether factors other than the histological subtype can guide treatment 
of BCC. Multiple studies have evaluated clinical ulceration, tumour thickness and adnexal 
extension in sBCCs as determinants of treatment failure.13-16 However, the association between 
these parameters and non-invasive treatment outcome is still uncertain. 
This retrospective study sought to analyse the sampling error within a 3 mm punch biopsy 
suspicious for BCC by evaluating the current histological examination method using a revised 
examination process. Because the therapeutic impact is the highest for mixed type BCC in which 
a sBCC is found and a more aggressive BCC subtype (nBCC, mnBCC, iBCC) is missed, the 
focus will be on sBCC. The secondary objective was to aid in developing a standard sectioning 
protocol for BCC. Furthermore, we investigated whether tumour thickness, ulceration and 
adnexal extension are determinants of treatment failure or recurrence in initial diagnosed sBCCs 
treated with MAL-PDT, Imiquimod or 5-FU. 
Materials and methods
This retrospective study was approved by the institutional review board of the Radboudumc, 
Nijmegen, the Netherlands. 
Population
The McNemar test was used for the power calculation with the following variables: α= 0.05, 
power=80% and probability= 1%. The prevalence of finding a sBCC subtype in histopathological 
diagnosed mixed type BCCs in excision specimens was at least 16%. This was deducted from the 
study of Wolberink et al.8 The prevalence of a superficial subtype in histopathological diagnosed 
mixed type BCCs in punch biopsies was estimated to be around 10%. Using this information, a 
sample size of 116 punch biopsies was determined. One hundred and sixteen sBCCs in the years 
2014-2015 were included. A chart-review was performed of punch biopsy proven primary sBCCs. 
Appropriate charts were selected from Radboudumc, using the Dutch pathologic anatomic 
national computerised database (PALGA). This database contains histopathological reports and 
diagnosis of all tissues evaluated by pathologists in the Netherlands. Superficial BCCs with 
the following criteria were included: (i) derived from 3 mm punch biopsies (ii) histopathological 
diagnosis of sBCC without any other BCC subtypes (iii) histological analysis involved sectioning 
in one level only (at approximately 1000 µm) after formalin fixation and paraffin embedding. 
Exclusion criteria were punch biopsies from patients with (i) genetic skin disorders (ii) using 
immunosuppressive medications (iii) previous radiotherapy (iv) previous documented BCC at 
the same location, which could represent a recurrent BCC. 




The included sBCC punch biopsies, embedded in paraffin blocks after tissue processing, were 
requested from the Department of Pathology, Radboudumc. The punch biopsies were cut at 
four levels at an interval of 200 µm. After every 200 µm, ten sections of 4 µm each were cut of 
which the middle two sections were stained with H&E and evaluated. A total of 5 levels per punch 
biopsy were available for histopathological evaluation (Fig. 1). BCC subtype classification was 
based on the Dutch guidelines.12 Superficial BCC was defined as nests of basaloid cells residing 
high in the dermis (above the level of the vascular plexus), usually in a multifocal pattern. Nodular 
BCC was defined by the presence of large, rounded tumour nests. Micronodular BCC resembled 
nBCC but with smaller nests. Infiltrative BCC consisted of irregular, non-rounded strands or nests 
of basaloid cells surrounded by desmoplastic stroma. Presence of adnexal extension of sBCC 
was defined as tumour cells along hair follicles or sebaceous gland ducts growing deeper than 
the deepest located tumour nest. Micronodular BCCs and iBCCs have the smallest BCC nests. 
The size of a mnBCC nest  is comparable to the bulbus of a hair follicle which is approximately 
270 µm.12,17 The choice of cutting step sections at 200 µm intervals was aimed to identify even 
small BCC nests. The sectioning, staining and evaluation of the H&E stained sections was done 
by a pathologist-in-training (GJK) at the Radboudumc. In case of doubt and/or in case another 
BCC subtype was observed, evaluation was also performed by a certified dermatopathologist 
(WAMB). Additionally, H&E stained sections from one out of every ten punch biopsies were also 
assessed by the dermatopathologist. The dermatopathologist was blinded for the diagnosis 
made by the pathologist-in-training. Tumour thickness was evaluated by measuring the basaloid 
nest from the stratum granulosum up until the deepest point of invasion using a 0.1 mm precise 
ocular micrometer. 
For all patients age and gender were recorded. For all included sBCCs the following data was 
assessed: location, size (<10 and >10 mm), histopathological diagnosis after examination of 
the additional sections, presence of ulceration and adnexal extension, tumour thickness, initial 
therapy given with corresponding treatment effect, histopathological diagnosis of the excision (if 
applicable) and follow up time (until 29-1-2016). In case of treatment failure, the histopathological 
diagnosis of the repeated punch biopsy and secondary therapy with corresponding treatment 
effect were also determined.  All included patients were treated with Imiquimod cream, 5-FU, 
excision or MAL-PDT. 
Statistical analysis
Patient and tumour characteristics were presented as numbers and percentages in case of 
categorical variables or as mean and standard deviations. The difference in sBCC tumour 
thickness in the initial H&E and additional H&E sections was analysed using the independent 
T-test. Follow up time was calculated from date of treatment to date of treatment failure, recurrence 
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Table 1. Demographics 
Patient characteristics N (%) Mean + SD
Gender
- Male 43 (48.3)
Age (years) 66.0  + 12.4
Tumour characteristics N (%) Mean + SD
Location













Presence of clinical ulceration
- Yes   1 (0.1)
Presence of adnexal extension
- Yes 13 (11.2)
Tumour thickness (mm)
- Initial H&E stained sections
- Additional H&E sections











Follow up time (days)2 312  + 194
1 p-value when compared to the initial H&E stained sections was 0.001.
2 Until 1-2-2016.
Table 2. Histopathological diagnosis
Diagnosis of punch biopsy n (%)1
Primary punch biopsy 
diagnosis2





sBCC 90 (77.6) 16 (13.8) 1 (0.9) 1 (0.9) 4 (3.4) 1 (0.9) 3 (2.6) 116 (100.13)
More aggressive subtype     26 (22.4) 
missed n (%)
1 Based on histopathological evaluation of 5 levels per punch biopsy.
2 Based on histopathological evaluation of 1 level per punch biopsy.
3 Numbers do not add up to 100 due to percentages round off.
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Table 3. Histopathological evaluation: presence of additional BCC subtypes
H&E stained sections in which other BCC subtypes are present1








1 No No No No Yes
2 No Yes Yes Yes Yes 
33,4 No Yes No No No
4 No No No Yes Yes 
5 No No Yes Yes Yes 
6 No No Yes No Yes 
7 No Yes Yes Yes Yes 
8 No No Yes Yes Yes
9 No No No Yes Yes 
10 No Yes Yes Yes Yes
11 No Yes Yes Yes Yes
12 No No Yes Yes Yes
13 No No No Yes Yes
14 No Yes Yes Yes No 
15 No Yes Yes Yes Yes 
16 No No No No Yes 
172,3 No No No Yes No 
18 No Yes No No Yes
19 No No No Yes Yes
20 No Yes Yes Yes Yes 
21 No Yes Yes Yes Yes
22 No Yes No No Yes
23 No No Yes Yes Yes
24 No No Yes Yes Yes 
25 No No No No Yes 
26 No No No Yes Yes 
Overall presence 
of additional BCC 
subtypes (%)
0 11 (42.3) 14 (53.8) 19 (73.1) 23 (88.5)
1 Other than superficial basal cell carcinoma subtype.
2 Other BCC subtype(s) missed when evaluating only 1st and 4th additional level.
3 Other BCC subtype(s) missed when evaluating only 2nd and 4th additional level.
4 Other BCC subtype(s) missed when evaluating only 3rd and 4th additional level.
 




In total, 116 punch biopsies of 89 patients (48.3% male; mean + SD age at analysis 66.0 + 12.4 
years, Table 1) were evaluated. The majority of sBCCs were located on the trunk (55.2%), smaller 
than 10 mm, did not show clinical ulceration or adnexal extension and were treated by excision. 
The mean sBCC tumour thickness in the additional H&E sections was larger than in the initial 
H&E (Table 1). This difference was statistically significant. Follow up was available for all lesions 
with a mean of 312 + SD 194 days.  In 22.4% of the lesions (n= 26) other BCC subtypes (nBCC, 
mnBCC, iBCC)  were found in the additional H&E sections (Table 2). The BCC diagnosis, after 
evaluating 5 levels of the punch biopsy, is shown in Table 2. The presence of additional BCC 
subtypes per sectioning level is depicted in Table 3 (Fig. 2). Clinical recurrences were present 
in two cases (1.7%) which were also confirmed by a second punch biopsy (Table 4). In two 
lesions that were treated with PDT, one showed no response and one showed partial response. 
In 25% (n=1) of the treatment failure and recurrence group the sBCC was thicker than 0.4 mm. 
Ulceration and adnexal extension did not occur in this group.  
Discussion
BCC management is mainly based on the expected biological behaviour that correlates highly to 
the histological BCC subtype. Treatment modalities have expanded and the usage of non-surgical 
treatments have increased. However, these treatments are only suitable for sBCCs. Therefore, 
correct diagnosis of sBCC is of great importance. Currently, the punch biopsy is the gold 
standard for detection of BCC subtypes. However, a standardised method for histopathological 
examination of punch biopsies in lesions suspicious for BCC is missing. For this reason, the 
aim of this paper was to evaluate the accuracy of the current histological examination method 
in sBCC punch biopsies using a more extensive step section method. Furthermore, we sought 
to investigate whether tumour thickness, ulceration and adnexal extension are determinants of 
treatment failure or recurrence in sBCC treated with MAL-PDT, Imiquimod or 5-FU. The overall 
accuracy of sBCC punch biopsies that are histopathologically evaluated in only one level was 
77.6%. Thus, in almost one out of every four sBCC a more aggressive BCC subtype was missed. 
Hoogedoorn et al. analysed the treatment failure and recurrence of sBCC following MAL-PDT. 
They discovered that more than half of the treatment failures was due to underdiagnosis of 
the primary punch biopsy.18 In those tumours, a more aggressive subtype was detected that 
was missed in the primary punch biopsy. In approximately 50% of the recurrences a mixed 

























































































































































































































































































































































































































































































































































































































































































































































































biopsies and excision specimen. Because the punch biopsy represents only a small part of 
the entire tumour, sampling error of the location of the punch biopsy can also play a role in the 
underdiagnosis. This sampling error might be the reason why in one of our patients, who had 
a partial response to MAL-PDT, the histopathological diagnosis of the punch biopsy did not 
match the diagnosis of the excision specimen (Table 4). These authors also reported a higher 
number of clinical treatment failures (6.0%) and recurrences (9.2%) compared to our study.18 
Their median follow up period was two years. The short follow up period in our study might be 
the reason that no association was found between presence of a more aggressive BCC subtype 
in the punch biopsy and treatment failure or recurrence. 
Studies have shown that  sBCCs with tumour thickness > 0.4 mm are significantly more likely to 
recur after treatment with Imiquimod and that ulceration and tumour thickness were associated 
with lower response to MAL-PDT.14,15 The follow up period in these studies ranged between a 
mean of 23.5–34 months, with a median between 20–27.3 months. In our treatment failure and 
recurrence group, however, ulceration and adnexal extension were not present and only one 
patient in this group had a tumour thickness of more than 0.4mm. Therefore, we did not see an 
association between these features and treatment failure or recurrence. 
BCC nests can be the size of a few micrometers. Detection of BCC nests smaller than 200 µm 
can be missed with histological examination of only one level in a punch biopsy. However, the 
choice of cutting step section intervals of a few micrometers, to identify even the smallest BCC 
nest, would result in a too labour-intensive protocol. Moreover, the clinical implications of the 
smallest BCC nests are still controversial. Therefore, cutting step section intervals at 200 µm 
intervals was chosen because this was a more affordable protocol. According to this study, 
the misdiagnosis of punch biopsies was lower, compared to the current protocol, when using 
cutting step sections of approximately 440 µm after the initial H&E stained sections. This leads 
to examination of only the 2nd and 4th additional H&E stained sections (Table 3). The number of 
missed mixed type BCCs was even smaller when H&E stained sections were examined from the 
1st and 4th or 3rd and 4th additional levels. Though, this would lead to varying cutting step section 
intervals that may be confusing and more difficult to apply in daily practice. 
The whole punch biopsy was not cut up in sections entirely because the Radboudumc regulates 
that a part of the punch biopsy has to be available in case of future testing. Therefore, there is 
a possibility of missing a BCC nest in the remaining tissue. However, 9.5-18% tissue shrinkage 
can occur during formalin fixation and histological processing, embedding and mounting.19-22 
This leaves only a small section of tissue that remains unevaluated after additional sectioning. 
Non-invasive skin imaging techniques such as the reflectance confocal microscopy (RCM) 
might be helpful for the diagnosis of the BCC subtype prior to treatment. Studies have shown 
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the ability of RCM to distinguish the BCC subtypes.23,24 RCM was also able to detect subclinical 
BCC recurrences. 25 Peppelman et al. have set up a randomized controlled trial to determine 
the accuracy of RCM in identifying BCC subtypes and the cost-effectiveness compared to 
punch biopsy. In future, non-invasive techniques can aid in establishing a more accurate BCC 
diagnosis as evaluation of the whole tumour can be performed prior to treatment and possibly 
lead to a higher cost-effectiveness.26
In conclusion, this study shows that in more than 20% of the punch biopsies, diagnosed as 
sBCCs, more aggressive subtypes are missed with histological examination of only one level 
from a punch biopsy. We recommend step sectioning (such as 5 levels of 200 µm) in case of a 
diagnosis of sBCC to reduce the risk of missing more aggressive BCC subtypes and to prevent 
undertreatment. We plan to monitor the study patients for another two years to extend the follow 
up period in order to evaluate whether the detection of a more aggressive BCC subtype is 
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Is an one-day patient friendly methyl 
aminolevulinate photodynamic 
therapy illumination scheme for 
superficial basal cell carcinoma 













Background: Topical methyl aminolevulinate photodynamic therapy (MAL-PDT) is highly effective 
for the treatment of superficial basal cell carcinoma (sBCC). However, current European MAL-
PDT protocol requires at least two hospital visits, which is costly and unpractical for patients. The 
aim of this study was to evaluate the effect of fractionated MAL-PDT on the same day, using two 
light fractions at 3 and 4 hours compared to illumination at 3 and 5 hours after MAL-application, 
in a randomised multicenter pilot trial.
Methods: Thirty patients were randomised into two groups. The first group received illumination 
at 3 and 4 hours (20 + 55 J/cm2) after MAL-application. In the other group, two light fractions 
were performed at 3 and 5 hours (20 + 55 J/cm2) after MAL-application. The lesion response was 
evaluated at 3 and 12 months after treatment. 
Results: In the group, illuminated at 3 and 5 hours, 70.0% showed a complete response at 
3 months compared to 63.6% in the other group. At 12 months, 80.0% showed a complete 
response in the group, illuminated at 3 and 5 hours, compared to 72.7% in the other group. A 
total of 5 clinical treatment failures and recurrences occurred, of which 3 appeared to be mixed 
type BCCs. 
Conclusion: MAL-PDT, using two illumination sessions on the same day, is effective in the 
treatment of sBCC. A larger clinical study is needed to evaluate the benefit of fractionated MAL-
PDT over the current protocol. 
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Introduction
Basal cell carcinoma (BCC) is the most common type of skin cancer with an increasing incidence 
worldwide, becoming an important health problem accompanied with rising health care costs.1-3 
There are different histological BCC subtypes including infiltrative (iBCC), micronodular 
(mnBCC), nodular (nBCC) and superficial BCC (sBCC). While nBCC is the most common type, 
a significant increase in the superficial subtype is noticed.4 Although, surgery is an appropriate 
treatment option, sBCC is also suitable for non-surgical treatment modalities, since it is easy 
accessible with topical treatment. Non-surgical treatment options include photodynamic therapy 
(PDT), Imiquimod cream, 5-Fluorouracil (5-FU) cream, cryosurgery or electrodessication and 
curettage.5 Photodynamic therapy has been recommended as a first-line treatment for sBCC 
by an international consensus.6 PDT involves the application of a topical photosensitizer or its 
prodrug, in most cases aminolevulinic acid (ALA) or its methylated ester methyl aminolevulinate 
(MAL). In the heme biosynthetic pathway ALA and MAL are endogenously converted into 
protoporphyrin IX (PpIX). After application, an optimal time interval is needed for the production 
and accumulation of PpIX in the target cells. There is preferential production of PpIX in malignant 
cells. Thereafter, illumination of the lesion results in the formation of reactive oxygen species 
triggering apoptosis and necrosis of the target cells.7 
Methyl aminolevulinate is the photosensitizing agent approved for PDT of sBCC and/or nBCC.8 
The current European protocol for MAL-PDT in sBCC consists of two light fractions (37 J/cm2) 
one week apart, repeated at 3 months if required.5,6,9,10 Three hours after application of MAL 
cream, the cream is wiped off and the tumour is illuminated with a light source with non-coherent 
red light (630 nm). However, the double procedure is unpractical for patients. Furthermore, the 
required day care visits result in high treatment costs, which are mainly attributed to general 
hospital overhead and personnel costs.11 Therefore, a MAL-PDT protocol requiring two 
illumination fractions on the same day would be more practical for patients and result in reduced 
treatment costs. 
In ALA-PDT, multiple studies have shown the benefit of splitting the illumination into two light 
fractions over a single illumination session.12-14 This is due to re-synthesis of PpIX during the 
dark interval between two light fractions.15-17 Also in MAL-PDT, there is re-synthesis of PpIX after 
illumination.18 Further studies have tried to optimise fractionated ALA-PDT. Robinson et al. 
showed that a low dose light fraction followed by a high dose light fraction results in a higher 
efficacy of ALA-PDT compared to delivering two equal light fractions.19 De Bruijn et al. showed 
a significant trend for increasing skin damage after PDT with increasing length of dark interval.20 




There is one clinical study on mouse skin that investigated the response of MAL-PDT using a 
single and a two-fold illumination scheme and compared that to ALA-PDT.18 Four hours after 
ALA or MAL application, the skin was illuminated using either a single light fraction (100 J/cm2) 
or a two-fold illumination scheme (5 + 95 J/cm2) with a two hour interval. They showed that 
fractionated illumination did not enhance the clinical efficacy of MAL-PDT, as was the case when 
using ALA. However, the optimum illumination scheme for MAL-PDT is 3 hours after application 
and not 4, as is the case in ALA-PDT.21 Furthermore, this study was performed on normal mouse 
tissue and not on human tumour tissue and MAL is known to be more tumour selective than 
ALA.22,23 
Therefore, the aim of this study was to evaluate fractionated illumination of MAL-PDT in patients 
with sBCC lesions. We compared two light fractions (20 + 50 J/cm2) of MAL-PDT with one or 
two hours interval: illumination at 3 and 4 hours compared to illumination at 3 and 5 hours after 
MAL-application. The total light dose was 75 J/cm2, according to the standard MAL-PDT protocol 
for sBCC (two sessions of 37 J/cm2, one week apart with a 630 nm lamp). 
Materials and methods
Patients 
This investigator-initiated, prospective, single-blinded, randomised multicenter pilot trial was 
conducted from June 2013 until October 2016 at the Radboud university medical center 
(Radboudumc), Nijmegen and Maxima Medical Center (MMC), Eindhoven, The Netherlands. The 
study was approved by the ethics committee (NL41859.091.12) and was conducted according 
to the Declaration of Helsinki. Due to the preliminary aspect of the study, a small sample size 
of 30 patients was used. All patients provided written informed consent. Patients above the age 
of 18 years with a histological proven (3 mm punch biopsy) primary sBCC were included. From 
each patient, one sBCC was included. Exclusion criteria were patients with a known allergy to 
MAL or related compounds, participation in other clinical studies, received treatments in the 
last 12 weeks for skin cancer in the area to be treated, usage of chronic immunosuppressive 
medication and patients who were pregnant or breastfeeding. Patients were randomized into 
two groups in a 1:1 ratio using a sealed envelope system generated by a research nurse. The 
first group received illumination at 3 and 4 hours after MAL cream application. The second group 
was illuminated at 3 and 5 hours after application of MAL. Randomisation occurred prior to pre-
treatment of the lesion. The research physician, who enrolled the patients and assessed the 
lesion response, was blinded to the assigned treatment. Patients and treating physicians were 
not masked for the assigned therapy. Lesion sizes were determined clinically. An ellipse formula 
(πab/4) was used to calculate the lesion area from the smallest (a) and largest dimension (b). 
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MAL-PDT  treatment protocol 
Salicylic acid 10% in vaseline daily for one week or an adhesive dressing (DuoDERM®, ConvaTec 
Inc.) was applied prior to PDT if necessary. A MAL cream was used (Metvix®, 160mg/g, 
Galderma). First, a layer of MAL cream (approximately 1 mm thick) was applied to the lesion 
and to the surrounding 10 mm of normal skin. The tumour site was covered with an adhesive, 
occlusive dressing (Tegaderm®, 3M Health Care Ltd) and tinfoil to prevent influence of light. 
Three hours after application, the cream was wiped off and the tumour was illuminated using 
the 630 nm Aktilite® CL 128 lamp (Galderma). The lesion, including a margin of at least 10 mm 
was illuminated. The first illumination session took around 4 minutes (20 J/cm2) and the second 
session around 12 minutes (55 J/cm2). The possibility of pain sensations during illumination was 
explained to the patients and they were given the choice of no medication or Acetaminophen 
(1000 mg the day before, in the morning of and/or one hour before treatment). The Visual 
Analogue Scale (VAS) score was used to assess the extent of pain that the patients endured 
during illumination. 
Lesion response
The lesions were clinically evaluated at 3 and 12 months after treatment. At each visit, the clinical 
treatment response (complete, partial, no response), lesion reduction and possible adverse 
events were evaluated. Complete responses (CR) were defined as 100% clinical visual clearance 
of the sBCC. Partial responses (PR) were defined as > 50% reduction in the greatest diameter. No 
responses (NR) were assessed as < 50% reduction in the greatest diameter. Photographs were 
taken at each follow up visit, unless no change was observed. A punch biopsy was performed 
in case of suspicion of a residual or recurrent BCC. If necessary, the choice of an additional 
treatment was determined by the treating physician. 
Histopathological examination process
During the study, all punch biopsies were routinely histologically examined with hematoxylin 
and eosin (H&E) stained tissue sections obtained from one level (at approximately 1000 µm). 
Superficial BCCs were histologically defined as nests of baseloid cells residing high in the 
dermis, usually in a multifocal pattern.24 After the PDT study, all punch biopsies were sectioned in 
4 additional levels with an interval of 200 µm, in order to evaluate whether more aggressive BCC 
subtypes might have been missed using the routine protocol. After every 200 µm, 10 sections 
of 4 µm each were sectioned of which two sections were stained with H&E and evaluated by a 
pathologist-in-training (GJK) and pathologist (WAMB). BCC subtype classification was based 
on the Dutch guideline.25 Tumour thickness was evaluated by measuring the basaloid nest from 





Descriptive statistics, including median and range for continuous variables and percentages for 
categorical data, were used to explore patient and tumour characteristics. The Mann-Whitney 
test and Fisher’s exact test were used to compare continuous and categorical variables between 
groups, respectively. The Spearman’s rank-order correlation was used to assess whether there 
was an association between the amount of Acetaminophen used prior to illumination and the 
VAS score after the first and second illumination. In case a more aggressive BCC subtype was 
detected in the punch biopsies, that were sectioned in additional levels, follow up time was 
calculated from date of MAL-PDT treatment to date of second treatment or last (post-study) 
follow up (until January 2017). A p-value of < 0.05 was regarded statistically significant. Statistical 
analyses were performed using IBM SPSS Statistics 22.0 (SPSS Inc., NY, USA).
Results 
Between June 2013 and July 2015, 30 patients with sBCCS were enrolled; 16 patients of the 
Radboudumc and 14 of the MMC. Eight patients were excluded due to non-adherence to the 
protocol (no punch biopsy obtained (n=6), more than one lesion per patient illuminated (n=2)) 
and one patient was lost to follow-up. The remaining 21 patients were included in the analyses. 
Patient and tumour characteristics were comparable in both groups (Table 1). 
Three months post-treatment, both groups showed CR rates between 63.6-70.0% (Table 2). In 
the group, illuminated at 3 and 4 hours, 7 out of 11 sBCCs (63.6%) showed a CR after 3 months, 
while 3 sBCCs (27.3%) showed a PR (Table 2). A punch biopsy was obtained from one of the 
partial responsive lesions, which revealed a sBCC. This lesion was marked as a treatment failure 
(9.1%) and treated with Imiquimod with a good effect. One lesion (9.1%) remained the same 
size, but showed minimal erythema. This lesion was listed as NR and was followed up. Seven 
out of 10 lesions (70.0%) in the group, illuminated at 3 and 5 hours, showed CR after 3 months. 
From 2 of the 3 partial responsive lesions, punch biopsies were performed and both revealed 
sBCCs. However, after surgical excision, both lesions appeared to be mixed type BCCs. The 
other PR lesion was followed up.
The CR rate after 12 months was 8 (72.7%) and 8 (80.0%) for respectively the groups, illumination 
at 3 and 4 hours and at 3 and 5 hours (Table 2). In the group, illuminated at 3 and 4 hours, 2 
BCCs showed PR (18.2%); one of these was detected at an extra visit 5 months after illumination. 
Punch biopsies from these PR lesions revealed sBCCs (n=2) of which one was a treatment 
failure and the other one a recurrence, since it showed a complete response earlier at an extra 
visit 6 months after illumination. After surgical excision of these lesions, one was diagnosed as a 
sBCC. However, the other appeared to be a nBCC.  
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Table 1. Patient and tumour characteristics separated by treatment group
Patient and tumour characteristics Illumination at 3 and 4 hours  
(n=11)




































sBCC lesion size (mm2) 78.5 [39.3-176.7] 78.5 [47.1-188.5]
Pretreatment sBCC
- No 








 n.a., not applicable; sBCC, superficial basal cell carcinoma.
Continuous variables are displayed by median and [range], categorical variables are displayed by absolute 
counts and (proportion).
No statistical differences were noted between the groups at 3 and 12 months with respect to lesion 
responses and median lesion size reduction. The median VAS scores after the first illumination 
were 3 and 4.5 and after the second illumination 4 and 4 for the group illuminated at 3 and 4 
hours and 3 and 5 hours respectively (Supplementary table 1). No significant differences were 
found in the median VAS scores between the two illumination groups. There was no association 
between the Acetaminophen dose prior to illumination and the VAS score after illumination. 
Moreover, no serious adverse events were reported (Table 2). 
Histopathological examination
Twenty-six punch biopsies (21 initial and 5 post-treatment biopsies) were available for additional 
sectioning (Table 3). In 4 punch biopsies (3 initial and 1 post-treatment biopsies), other BCC 
subtypes were detected after additional sectioning. They showed 3 nBCCs (Table 3; patients 6, 
12, 17) and one mixed type BCC with nodular and infiltrative components (Table 3; patient 8). 
Two of these lesions (patients 6 and 8) were treatment failures which were surgically excised. 
The median follow up time for these lesions, until their second treatment, was 612 days [range 
276-947 days]. The other two (patients 12 and 17) did not show any clinical signs of treatment 
failure or recurrence after treatment and therefore continued their (post-study) routine dermato-
oncological follow up at their respective hospitals. The median follow up time (including time of 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Supplementary table 1. Results VAS-scores and adverse events after illumination
After illumination
Illumination at 3 and 4 hours Illumination at 3 and 5 hours p-value 
Median VAS score after 
1st illumination [range]
3 [0-7.0] 4.5 [2.0-7.0] 0.173
Median VAS score after 
2st illumination [range]
4 [0-8.0] 4 [2.0-8.0] 0.603
Adverse eventa 1 (local itchiness) 0
VAS score, Visual Analogue Scale score.
a Adverse event: related to MAL-PDT treatment, during or directly after illumination.
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Discussion 
Current MAL-PDT treatment for sBCC requires two treatment sessions on separate days, and 
repeated after 3 months if necessary. This requires at least two hospital visits for patients, which 
is unpractical and costly. Therefore, optimisation of this protocol might be more beneficial to 
patients and reduce treatment costs. Therefore, the purpose of this study was to evaluate two 
different MAL-PDT protocols in which two light fractions were performed on the same day, with 
one or two hours interval. 
Overall, this pilot study shows that two sessions of illumination on the same day leads to CR 
rates between 72.7-80.0% at 12 months. Though, a comparison of our results with other studies 
is challenging because of differences among studies on key elements, such as PDT-procedure, 
selection of lesions, length and methods of follow up and endpoint assessment. There are two 
larger prospective studies that are more in line with our study design.26,27 They show higher CR 
rates at 12 months compared to our study. However, the high CR rate in the study of Szeimies et 
al. is due to the fact that sBCCs, that showed incomplete response at 3 months, received 2 further 
MAL-PDT sessions (75 J/cm2). Furthermore, Basset-Seguin et al. showed comparable results at 
3 months when one single session of MAL-PDT (light dose 75 J/cm2) was given after sBCCs were 
treated with MAL-cream 3 hours prior to illumination.28 This leads to the question whether it might 
be easier to perform one illumination session of 75 J/cm2 instead of re-illumination at 4 and 5 
hours. However, the incomplete responders in the study of Basset-Seguin et al. were, thereafter, 
treated with 2 MAL-PDT illumination sessions one week apart at 3 months. For that reason, there 
is no information on the long term effect of a single illumination session. Therefore, a study with a 
larger population comparing a single MAL-PDT illumination session (75 J/cm2) and fractionated 
MAL-PDT (20 + 50 J/cm2) with a longer follow up period is recommended. 
In this study, some lesions showed less erythema after PDT compared to before treatment, or 
mild remaining erythema possible due to scarring of the biopsy location or after PDT treatment. 
According to our strict definitions of ‘lesion response’, these lesions were marked PR or NR. 
However, not all these lesions were not clinically suspect for a treatment failure or recurrence. 
Therefore, not all of them were biopsied. This is also the reason why some lesions, which 
appeared as PR or NR at 3 months, showed CR at 12 months. 
All adverse events that were reported in this study were in accordance with other studies.26,29 
Furthermore, no serious adverse reactions occurred. Arits et al. showed in their study that serious 
adverse events only occurred in patients treated with Imiquimod and 5-FU but not in the MAL-
PDT treatment group.26 More importantly, a generally better cosmetic outcome is observed after 
PDT treatment of sBCC compared to other treatment options.26,27 Furthermore, the treatment 
regime for Imiquimod and topical 5-FU is intensive and long (4-6 weeks). 30 In daily practice, 
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not all patients will be motivated or able to apply a cream for such a long period. For these 
patients, hospital-based treatments such as MAL-PDT and surgical excision might be preferable. 
In case both treatments can take place during one visit, MAL-PDT may have the benefit over 
surgical excision, especially when cosmetic outcome and problematic healing sites are taken 
into consideration. 
The 5 treatment failures and recurrences in the present study were partly due to the presence of a 
more aggressive BCC subtype in the excision specimen, most probably caused by sampling error 
or histological underdiagnosis of the punch biopsy. In 3 lesions, other BCC subtypes (nodular 
and infiltrative) were detected in the excision specimen. Although, MAL-PDT is also effective in 
nBCC, poorer clearance rates and higher recurrences were seen in these tumours compared 
to sBCCs.27,31,32 Moreover, MAL-PDT is not registered for the treatment of iBCC. Histological 
underdiagnosis of the punch biopsies may have led to an increased number of treatment failures 
due to undertreatment. In order to reduce the risk of sampling error, additional sectioning of the 
punch biopsy can be performed.33,34 This might result in a more accurate diagnosis for adequate 
treatment. In our study, additional sectioning of the punch biopsies yielded the detection of 4 BCCs 
with a more aggressive BCC component, of which 3 were from the primary punch biopsies. Two 
of the lesions (one from the 1st and one from the 2nd punch biopsy) were treatment failures and 
removed by surgical excisions. The other two did not show any clinical signs of treatment failure 
or recurrence after MAL-PDT (median follow up period more than 2 years). In these two lesions, 
MAL-PDT seemed to be an effective treatment. A hypothesis for this might be that MAL-PDT is more 
effective in nBCCs with a small tumour thickness (Table 3; patient 17) compared to nBCCs with a 
larger tumour thickness (patients 6 and 12). On the other hand, one nBCC lesion with a large tumour 
thickness (patient 12) had a good clinical effect after MAL-PDT (follow up approximately 2 years). 
There is a chance that this lesion might recur after an extended follow up period, like in the study 
of Roozeboom et al., where they noticed treatment failures 3 years after MAL-PDT.35 Therefore, this 
patient remains in (post-study) routine clinical follow up. One mixed type BCC was not detected 
after additional sectioning of the primary punch biopsy (Table 3; patient 4). This may have been 
a result of sampling error of the punch biopsy. The usage of non-invasive diagnostic techniques, 
such as the reflectance confocal microscopy (RCM), may reduce sampling errors as they offer the 
possibility to image the whole lesion and distinguish different BCC subtypes.36,37 Overall, various 
options are available to reduce sampling errors resulting in higher cost-effectiveness, because 
they prevent the need for repeated biopsies and subsequent treatment. 
In conclusion, this study shows that MAL-PDT, given in a two-fold illumination scheme with one 
or two hours interval, shows promising results in the treatment of sBCC. Though, a larger clinical 
study is needed to evaluate the benefit of fractionated MAL-PDT over a single MAL-PDT session 
and the regular MAL-PDT protocol. 
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3.1
The current role of reflectance 
confocal miscroscopy within the 
continuum of actinic keratosis 












Background: Clinical differentiation between actinic keratosis (AK), squamous cell carcinoma 
(SCC) in situ, invasive SCC and its variants can be difficult. Reflectance confocal microscopy 
(RCM) is a non-invasive technique for in vivo skin imaging.
Objectives: To explicate the diagnostic and monitoring use of RCM within the spectrum of AK 
and SCC by presenting the corresponding RCM features. Additionally, to evaluate the accuracy 
of RCM for these diagnoses compared to histopathology. 
Materials & methods: A systematic literature search was performed in PubMed, EMBASE, 
Cochrane Library and Web of Science databases. The quality was assessed using the 
STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) checklist.
Results: Twenty-five eligible studies were included. Different diagnostic RCM features have 
been described for AK, actinic cheilitis (AC), erythroplasia of Queyrat, Bowen disease, invasive 
SCC and keratoacanthoma (KA). The overall sensitivity and specificity of RCM for the diagnosis 
of SCC, AK, SCC in situ and KA ranged between 79-100% and 78-100%, respectively.
Conclusion: Current literature describes the use of RCM for diagnosing AK, AC, erythroplasia 
of Queyrat, Bowen disease, invasive SCC and KA, and for monitoring of AK treatments, with a 
good accuracy. Unfortunately, studies of high methodological quality are lacking. Pre-treatment 
of hyperkeratotic lesions and uniform definitions of RCM features are required to aid in the 
differentiation between AK, SCC in situ, SCC and its variants in clinical practice.  
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Introduction 
Actinic keratoses (AKs) are common precancerous skin lesions. AKs may progress to invasive 
squamous cell carcinomas (SCCs) ranging from 0-0.075% per lesion per year, with a risk up to 
0.53% per lesion in patients with a history of non-melanoma skin cancer (NMSC). 1 Therefore, they 
represent an early point on the continuum of malignancy. Early recognition of SCC is important, 
as it accounts for the majority of NMSC-related metastases and death.2 Clinical differentiation 
between AK, SCC in situ, invasive SCC and its variants can be difficult, but is important because 
of the associated risk of mortality. Bowen disease (BD) and erythroplasia of Queyrat (EoQ) are 
considered SCCs in situ, whereas verrucous carcinoma (VC) is a rare low-grade variant of SCC.3 
Keratoacanthomas (KAs) are characterized by the proliferation of highly, differentiated squamous 
epithelia. Clear distinction from a highly differentiated SCC is often impossible.3 Therefore, some 
regard them to be a variant of SCC. Dermoscopic features for AKs, SCCs in situ, invasive SCCs 
and its variants have been described but lacked diagnostic accuracy.4-6 Therefore, routine 
histopathology remains the gold standard. However, a biopsy procedure is invasive, may cause 
local inflammatory reactions and might result in sampling error and scarring. For that reason, 
non-invasive diagnostic technologies such as the reflectance confocal microscopy (RCM) have 
been proposed. RCM uses a near infrared laser of 830 nm and can image the skin until a depth 
of approximately 250 µm. It offers in vivo imaging of the skin with cellular resolution and has the 
potential to overcome problems that are associated with biopsy sampling. 
RCM has been described to be useful for the diagnosis of inflammatory skin conditions, 
melanocytic lesions and NMSC, especially basal cell carcinoma.7-13 In the area of NMSC, 
particularly AK and SCC, the knowledge and experience with RCM is increasing.14-17 However, 
due to lack of a systematic approach in the current reviews, which did not highlight all diagnoses 
within the continuum of AK and SCC, we aimed to systematically appraise and summarize the 
available primary literature reporting data on the diagnostic and monitoring use of RCM within 
the spectrum of AK and SCC by presenting the corresponding RCM features. Furthermore, this 
review evaluates the accuracy of RCM for these diagnoses compared to histopathology. 
Methods 
A search strategy was developed based on RCM, AK, SCC in situ, invasive SCC and its variants 
deducted from the classification scheme in Dermatology.3 The literature search was performed in 
four electronic databases: PubMed, EMBASE, Cochrane Library and Web of Science using the 
search terms “confocal microscopy” or “confocal laser microscopy” or “confocal laser scanning 
microscopy” combined with “actinic keratosis”, “precancerous conditions”, “squamous cell 
carcinoma”, “Bowen disease”, “keratoacanthoma”, “verrucous carcinoma”, “erythroplasia of 
Queyrat” or “actinic cheilitis” and all synonyms. Currently, the most widely used RCM is the 
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Vivascope 1500. Other devices for in vivo imaging include the Vivascope 1000 (precursor of 
the Vivascope 1500) and the Vivascope 3000 (handheld device). Articles with patients that had 
a histopathologically proven diagnosis, of the Vivascope system only and with diagnostic and/
or monitoring RCM features and/or the diagnostic accuracy compared to histopathology were 
included. Publications describing diagnoses in medical specialty fields other than dermatology, 
unavailable texts, reviews and conference abstracts were excluded. Studies were restricted to 
the English, Dutch or German language and limited to humans. All published studies until March 
22, 2016 were included. 
Titles, and when necessary abstracts and keywords, were scanned by a review author (KPN). 
Thereafter, two reviewers (KPN and MP) screened title and abstract, and if required, material 
and methods. Following this selection, the two reviewers critically assessed the full texts for 
their eligibility. Differences in assessment between the two reviewers were discussed with a third 
(PEJVE) and fourth investigator (MJPG). Data extraction for all studies meeting the inclusion 
criteria was performed by two authors. The STrengthening the Reporting of Observational 
studies in Epidemiology (STROBE) criteria was used to assess the quality of the research.18 
Modifications to this scale were made by excluding the items ‘variables’ and ‘study size’ to 
evaluate the quality of case reports and case series. Studies were graded into the following 
categories, A: fulfilling more than 80% of the STROBE criteria (high); B: 50-80% (moderate); C: 
less than 50% (low). 
Results
The search strategy identified 2396 articles (Fig. 1). The first selection resulted in 169 articles 
on RCM and diagnoses within the spectrum of AK and SCC. The second selection resulted 
in 95 abstracts eligible for full text screening and yielded an overlap of 94% between the two 
reviewers. The full text screening resulted in 25 included articles and had an overlap of 87% 
between the two reviewers (Fig. 1). Twenty-five publications were included with articles on AK 
(n=15), AC (n=1), EoQ (n=1), BD (n=7), SCC (n= 8), and KA (n=2) (Table 1). The included 
studies consisted of case series (n=17),  case-controls (n=5), cohort studies (n=2) and case 
reports (n=1). The number of scanned lesions varied between 1-46 (AK), 1-25 (BD), 1-11 (SCC) 
and 3 (KA). The methodological quality of the studies varied between category B (n=13) and 
C (n=12) with a mean STROBE criteria percentage of 44.8 and standard deviation of 14.7. 
Eight studies determined the sensitivity and specificity of different RCM diagnoses compared 
to histopathology. Definitions and descriptions of the reflectance confocal microscopic features 
used in the studies are presented in Supplementary table 1.
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Figure 1: Flowchart selection procedure. 
This flowchart shows the number of publications identified, screened and included or excluded at each 
stage of the review process.
Actinic keratosis and actinic cheilitis
Thirteen studies depicted diagnostic and monitoring RCM features in non-pigmented AKs (Table 
1).14-16,19-27 Specific diagnostic RCM features for AKs are shown in Table 2. These conclusions 
were based upon case series and case controls with low to moderate methodological quality 
(Table 1).14 The same features were found for AC.28 Ulrich et al. showed that RCM features 
of AKs correlated well with routine histology.25 AKs predominantly had a focally disarranged 
or mildly atypical honeycomb pattern in the spinous-granular layer 15 and mostly showed an 
atypical honeycomb pattern or normal keratinocytes in the stratum granulosum.14,17 Four studies 
determined the diagnostic accuracy of RCM features for AKs.20,21,25,26 The sensitivity ranged 
between 91-100% and specificity between 78-100%. Ulrich et al. described a sensitivity of 86% 
and specificity of 100% for AC.28 Careful interpretation of these results is warranted, since all 
studies included a small number of cases. Moreover, Horn et al. only performed biopsies in 50% 
of the clinically suspected AK lesions and Incel et al. combined data from AKs and BD because 
of lack of distinctive features between both diagnoses.20,21 Two studies described RCM features 
for pigmented AKs (Table 1).29,30 Most observed features were similar to non-pigmented AKs with 




Eight studies of low to moderate methodological quality described RCM features for (non-)
pigmented BD (Table 1).15,21,22,26,31-34 General features of non-pigmented BD are displayed in 
Table 2. Ulrich et al. described two types of targetoid cells, each with its own characteristic 
morphologic appearance, corresponding to dyskeratotic cells.33 In addition to the RCM features 
found in non-pigmented BD, pigmented BD showed more RCM features (Table 2). These 
observations were all based on case series. The main study limitations were lack of a control 
group and a small population size. The highest number of scanned lesions per study did not 
exceed 25 BD lesions.15 Moscarella et al. showed a sensitivity of 100% for the detection of BD in 
collision tumours.32 Though the observers, who analysed the RCM images retrospectively, were 
blinded for the histopathological diagnosis, they were aware that the aim of the study was to 
evaluate collision tumours. This might have resulted in an information bias. Two studies depicted 
a sensitivity and specificity of respectively 93-97% and 97% for the combined diagnosis of AK 
and BD due to a lack of distinctive features between both diagnoses.21,26
Erythroplasia of Queyrat
EoQ was described by Arzberger et al. in a case control study (Table 1).35 The characteristic RCM 
features for EoQ are shown in Table 2, with a sensitivity and specificity each of 100%. 
Squamous cell carcinoma
RCM imaging of SCCs has been described in eight studies, consisting of case series and 
case controls (Table 1).14,15,17,19,21,36-38 The most described RCM features are listed in Table 2. 
Compared to AKs, the spinous-granular layer in SCCs showed more extensive atypia15, the 
severe architectural disarray was present in the stratum granulosum14,17,21 and the number of 
blood vessels and diameter of the vessels were increased.17 This latter can be explained by 
the higher metabolic need of the tumour.39,40 Peppelman et al. demonstrated that the presence 
of architectural disarray in the stratum granulosum in combination with architectural disarray in 
the stratum spinosum and/or nest-like structures were the best predictors for SCCs.17 Cinotti 
et al. reported a sensitivity of 100% to diagnose SCC with RCM, although, biopsies were only 
performed in 74% of the clinical suspicious lesions.36 The non-biopsied lesions were monitored 
for at least 12 months and showed no changes during that period. Incel et al. described a 
sensitivity and specificity of 79% and 99% respectively for the diagnosis of SCC and KA.21 
However, both studies included a small number of SCCs and therefore the diagnostic accuracy 
must be carefully interpreted. 
Keratoacanthoma and verrucous carcinoma
RCM features for KAs were described in two case series (Table 1).15,21 General features are listed 
in Table 2. Incel et al. excluded lesions with prominent hyperkeratosis.21 Both studies imaged a 
small number of lesions (n=3). There were no studies on the diagnostic accuracy of RCM in 
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diagnosing KA. Though, one study showed the sensitivity and specificity of 79% and 99% for the 
diagnosis of SCCs and KAs.21 No studies on RCM imaging of VC were found. 
RCM as a treatment monitoring tool
Monitoring RCM features for AKs and AC after treatment with topical 3% Diclofenac sodium 
with 2,5% hyaluronic acid and for AKs after shave biopsy have been described (Table 1).16,23,28 
A decrease in atypical honeycomb pattern in AKs and AC and changes in dermal collagen in 
AKs after treatment were observed. The reduction in epidermal atypia after topical treatment was 
confirmed by histopathological evaluation.16 Limitations of the studies were the small sample 
size, being non-randomized, uncontrolled studies and the exclusion of hyperkeratotic AKs. 
Discussion
Clinical differentiation between AK, SCC in situ, SCC and its variants can be challenging and taking 
a biopsy in these cases is an invasive method. Additionally, it inhibits monitoring of the same lesion 
after treatment. RCM may transcend these problems. To our knowledge, this is the first systematic 
review to explicate the use of RCM for all diagnoses within the continuum of AK and SCC, and to 
evaluate the accuracy of in vivo RCM imaging for these conditions compared to histopathology. 
Unfortunately, depth penetration imposes a major limitation on RCM in hyperkeratotic lesions, 
that is often associated with invasive SCCs. The inability of RCM to image at the level of the 
dermo-epidermal junction and stratum basale in potentially malignant hyperkeratotic lesions 
excludes important information from the diagnostic process. Instead, a distinction between SCC 
and AK using RCM must rely on the fact that in SCC extensive keratinocytic atypia involves 
the entire epidermis, including the stratum granulosum.14,15,17,20,31,33,41,42 Though, differentiation 
between SCCs and AKs remains challenging in hyperkeratotic lesions without visualization 
beyond the dermo-epidermal  junction. In SCC, nestlike structures and pleomorphic cells can be 
detected in the dermis, while these RCM features are absent in AK. 15,17 Careful curettage of the 
hyperkeratotic scale or pre-treatment with keratinolytic agents may evade this problem. 
Furthermore, it might be tough to differentiate between focal or extensive and mild or severe 
atypia. Therefore, experienced RCM observers and a high quality of image acquisitions are 
needed. A recent study of Pellecani et al. showed a significant correlation of the grading of 
keratinocyte atypia in AK between experienced, blinded RCM observers and histopathology.43 
Two distinct types of targetoid cells corresponding to dyskeratotic cells were described for BD.33 
However, dyskeratotic cells were also seen in SCC and AK but lacked clear definitions of their 
morphological appearances. Therefore, the two types of targetoid cells mentioned by Ulrich et 
al. may not be specific for BD. This also shows that there is need for uniformity in the definitions 
of RCM features for image assessment. 
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Regarding KA, it is possible that there was a lack of power to detect significant differences 
between KA and AK and SCC due to the small number of KA in the limited number of publications. 
Furthermore, the differentiation between VC and KA may be challenging. While VC commonly 
involves the subcutaneous fat and beyond, KA characteristically does not extend beyond the 
depth of the eccrine sweat.44 Therefore, a deep biopsy is essential. Due to the limited penetration 
depth of the RCM, it is unlikely that the diagnosis of VC can be made by this technique. 
Other studies have described the reduction of epidermal atypia in AKs after treatment with 
Imiquimod and photodynamic therapy.45,46 Ulrich et al. detected residual atypia in two AK 
lesion, one not showing a clinical treatment response and one showing clinical clearance, after 
treatment with Imiquimod.45 This was suggestive of incomplete clearance. They also developed 
a RCM atypia scoring system to evaluate the cellular changes in AK after treatment to facilitate 
the use of RCM. The authors concluded that, by using RCM as a monitoring tool to detect early 
residual atypia, the recurrence rates might ultimately decrease. 
In two case control studies, ‘normal looking’ skin adjacent to AK lesions14 or non-lesional skin 
from the contralateral side20 were used as controls. However, RCM imaging of these skin sites 
may not be adequate controls, due to the neoplastic changes across the entire sun field exposed 
field of skin caused by ultraviolet light.47,48 Jafari et al. detected discrete keratinocyte atypia at the 
level of the stratum spinosum, presence of solar elastosis and dilated blood vessels in clinically 
uninvolved skin sites perilesional from AKs.46 Therefore, a control group consisting of individuals 
with non-photodamaged skin and no history of UV-induced neoplasia may be more reliable. 
Current studies are promising and show an overall sensitivity and specificity of 79-100% and 78-
100%, respectively, for diagnosing AK, SCC in situ, SCC and its variants using RCM. However, 
no randomised controlled trials (RCTs) are reported on this subject. A RCT comparing RCM 
with punch biopsy or surgical excision in clinically suspected SCC can determine the diagnostic 
accuracy of the RCM for diagnosing SCC.
In conclusion, the current performed RCM studies are promising and show a variety of 
RCM features for the diagnosis of AK, BD, AC, EoQ, SCC and KA using RCM. Additionally, 
the monitoring RCM features after treatment of AKs and AC have been described. However, 
large, prospective, RCM observer-blinded RCTs, case-controls with a non-photodamaged skin 
controlgroup and cohort studies of high methodological quality are currently lacking. Curettage 
or pretreatment of hyperkeratotic lesions and uniform definitions of RCM features are necessary 
in order to identify RCM features that will aid in differentiating between AK, SCC in situ, SCC and 
its variants in clinical practice. 
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Table 2: Most frequently described diagnostic reflectance confocal microscopic  features
Diagnosis RCM features







Normal or atypical honeycomb pattern in SG
Architectural disarray in SG
Atypical honeycomb pattern or architectural disarray in SS









Densely packed, small and bright papillae
Ring of pigmented keratinocytes surrounding the hair follicle







Atypical honeycomb pattern and/or architectural disarray in SG and SS
(Epi)dermal small bright cells
With addition of:
Epidermal dendritic cells 
Dermal plump bright cells
Erythroplasia of Queyrat Atypical honeycomb pattern and/or architectural disarray in SG and SS
Round nucleated cells
(Epi)dermal small bright cells
Round papillary vessels
Squamous cell carcinoma Scale
Hyperkeratosis
Parakeratosis
Architectural disarray in SG
Atypical honeycomb pattern in SG
Atypical honeycomb pattern or architectural disarray in SS
Round nucleated cells 
Dilated blood vessels
Increased number of blood vessels
Nest-like structures in superficial dermis
Pleomorphic nucleated cells in superficial dermis
Keratoacanthoma Scale
Hyperkeratosis
Atypical honeycomb pattern and/or architectural disarray in SG and SS
Round nucleated cells
Abbreviations: RCM, reflectance confocal microscopy; SC, stratum corneum; SG, stratum granulosum; 
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Supplementary table 1: Definitions and descriptions of the reflectance confocal microscopic features used 
in the studies
RCM feature Definitions and descriptions
Anastomosing epithelial cords Corresponding to anastomosing bridges of basaloid cells in histopathology.42
Architectural disarray or disarranged 
pattern
Severe disarranged epidermal pattern, formed by atypical keratinocytes, in 
which the honeycomb pattern is no longer visible.15,16
Atypical keratinocytes Pleomorphic keratinocytes different in cell size and nucleus.19
Atypical or irregular honeycomb 
patterns
Deviation from the normal honeycomb pattern formed by irregular shaped 
keratinocytes.15,34
Cells with central dark nucleus in SC Correlating to parakeratosis.21
Coarse collagen bundles Bright fibrillar structures in the upper dermis forming a web-like arrangement.29
Cords Elongated bright tubular structures in the DEJ.29
Corneal pseudocysts Well circumscribed large, round, highly refractile intra-epidermal structures.29
Curled fibres Highly refractive thick and short fibres, sometimes forming compact masses in 
presence of solar elastosis.29
Curved linear vessel Curved linear dark spaces within dermal papillae that do not branch.21
Densely packed small and bright 
papillae
Round to polymorphous dermal papillae that are densely packed.29
Disruption/ individual cells or 
disruption of SC
Single, detached corneocytes in SC.28,29
Exocytosis Highly refractive, round structures in the epidermis corresponding to 
inflammatory cells.17
Huddled collagen bundles Large hyporefractive blotches of amorphous material in the upper dermis and in 
which individual collagen fibres are no longer visible.29
Impetiginisation The presence of very small bright structures corresponding to inflammatory 
cells in the stratum corneum.28
Keratin filled invaginations Round to longitudinal invaginations of the lesion surface, containing 
structureless amorphous material of various brightness.29
Large cells with aggregated bright 
nuclei
Corresponding to multinucleated keratinocytes.33
Lymphocyte rolling Lymphocytes within blood vessels appearing as round, high refractive cells.17
Mottled pigmentation Corresponding to clustered bright keratinocytes detectable in a honeycomb 
pattern.29
Nest-like structure Round, demarcated structures in the dermis that are often surrounded by 
fibrosis.17
Normal honeycomb pattern Uniform, regular spaced, broad keratinocytes forming a pattern resembling a 
honeycomb.17
Parakeratosis or polygonal nucleated 
cells in SC
Single, detached nucleated cells at the SC with sharp outlines and dark centre. 
29,33
Plump- bright cells Large, irregular shaped, bright cells with ill-defined borders and usually no 
visible nucleus corresponding to melanophages.22,29
Poorly defined and irregular 
keratinocyte cell borders
Poorly demarcated individual keratinocytes with broad and blurred cell 
borders.19
Round nucleated cells Cells with sharply refractive cell borders surrounding a dark nucleus 
corresponding to atypical or dyskeratotic keratinocytes.15
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Round papillary vessels Blood vessels that run perpendicular to the horizontal confocal imaging, 
producing a round appearance.15
Scale Increased thickness of SC seen as refractive amorphous material.29
Single round cells with a bright rim 
and central darkness
Most consisting with dyskeratotic keratinocytes.31
Small bright cells Bright cells without visible nuclei corresponding to inflammatory cells.35
Solar elastosis Bright dense bundles in the dermis with a lace-like appearance.28
Targetoid cell type 1 Large cell with a bright centre and a dark peripheral halo, correlating to a 
dyskeratotic keratinocyte separated from adjacent cells by a clear retraction 
halo.33
Targetoid cell type 2 A large cell with a dark centre and a bright rim surrounded by a dark halo, 
correlating to a dyskeratotic keratinocyte containing a pycnotic nucleus.33
Targetoid-like structures Large cell with a bright centre and a dark peripheral halo (targetoid cell 1) 
or large cell with a dark centre and a bright rim surrounded by a dark halo 
(targetoid cell 2) corresponding to dyskeratotic cells.33
Vermicular blood vessels Blood vessels that run parallel to the surface, producing a tortuous 
appearance.15
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Background: Early recognition of squamous cell carcinoma (SCC) is difficult. Non-invasive 
reflectance confocal microscopic (RCM) imaging of the skin is a promising diagnostic technique. 
Although several RCM features for SCC and actinic keratosis (AK) have been described, it is not 
determined whether RCM has the ability to distinguish between SCC and AK.
Objective: To determine in vivo reflectance confocal microscopic features that are specific for 
making a distinction between AK and SCC.
Methods: In 24 patients, 30 lesions clinically suspicious for AK or SCC were selected for RCM 
imaging. Following the imaging procedure, a 3 mm skin biopsy was obtained for confirmation 
of the histopathological diagnosis. Two observers evaluated the RCM images according to a 
literature based list of RCM features. The obtained data were evaluated by an univariate and 
forward multivariate logistic regression analysis, kappa analysis and independent T-test.
Results: The univariate logistic regression showed statistically significant odds ratios for several 
RCM features, including architectural disarray in the stratum granulosum, architectural disarray 
in the spinous layer and nest-like structures in the dermis. The forward multivariate logistic 
regression analysis showed that the combination of these features increased the ability to make 
the correct diagnosis AK and SCC non-invasively. The interobserver agreement between a 
starting and an experienced RCM observer ranged from poor to no agreement.
Conclusion: This study revealed specific RCM features that can distinguish between AK and 
SCC, stimulating further prospective large cohort research in this field. This will result in correct, 
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Introduction
Skin cancer is the most commonly diagnosed type of cancer in the Caucasian population, with 
rapid increasing incidence rates.1 Squamous cell carcinoma (SCC) and basal cell carcinoma 
are considered non-melanoma skin cancers (NMSC). The incidence ratio between those two 
NMSC types is approximately 1:4.2, 3 Despite the lower frequency, SCC accounts for the majority 
of NMSC related metastatic disease, making early recognition important.4
SCC arises out of epidermal keratinocyte dysplasia. These atypical keratinocytes penetrate 
the basal membrane in order to involve the dermis and deeper tissues. Actinic keratosis (AK) 
are commonly considered as premalignant skin lesions, which act as precursor to SCC. It is 
demonstrated that 0.1%–20% of all AK lesions can progress to invasive SCC. However, it is not 
possible to predict which lesion is at risk.5-7 The development of AK lesions is induced by e.g. 
ultraviolet radiation, causing damage to keratinocytes and their proliferation. In contrast to SCC, 
the basal membrane is not disrupted in AK lesions.4-6
The diagnosis of AK is mainly made upon clinical evaluation. In contrast, a lesion clinically 
suspected for SCC is confirmed by histological evaluation of a skin biopsy. However, the clinical 
distinction between AK and SCC can be difficult and is not always reliable.8 Dermoscopy can be 
useful in determining the diagnosis non-invasively. Although, in SCC and SCC in situ, glomerular 
or dotted vessels are often visible, but the absence of these vessels will not exclude the presence 
of a SCC.9-11 In addition, there may be some overlay between dermoscopic features of AK and 
SCC.10 Lastly, SCC is often difficult to visualize by dermoscopy because the scaly surface 
might obscure the underlying morphology.9 Therefore, routine histopathology remains the gold 
standard, although this entails patient discomfort, time and expenses. Moreover, the feasibility of 
obtaining biopsies from affected and surrounding skin sites is sometimes limited and can result 
in a sampling error. For these reasons, the interest in the development of non-invasive diagnostic 
methods to distinguish between AK and SCC is increasing. 
Reflectance confocal microscopy (RCM) is a non-invasive technique for in vivo imaging of the 
skin that uses near-infrared laser light. This technique produces horizontal images of the skin in 
shades of grey, with a resolution comparable to conventional histology.12 Non-invasive RCM is 
painless, can evaluate a larger area or the whole tumour, can image the exact same location over 
time and will not induce any kind of skin damage or inflammatory response. Further, artefacts 
caused by tissue processing during histopathological assessment can be avoided.13 
Currently, RCM is used for several dermatological purposes such as diagnosing and monitoring of 
inflammatory skin diseases, melanoma and NMSC, including SCC and its precursor AK.14-25 Several 
RCM features for AK and SCC have been described previously.9, 26-37 However, to the best of our 
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knowledge, there are no studies that have determined the ability of RCM to distinguish between AK and 
SCC in vivo. Therefore, the aim of this study is to determine, based on statistical evaluation, whether 
there are RCM features that are specific for making an in vivo distinction between AK and SCC.
Materials and methods 
Subjects
In 24 patients (12 men and 12 female), lesions clinically suspicious for AK or SCC were included 
for RCM imaging. The age of the patients ranged from 53 to 80 years, with a mean age of 
67 years. In 19 patients, a history of NMSC was documented. Four of these patients used 
chronic immunosuppressive drugs after kidney transplantation and one patient was treated with 
radiotherapy. Within all patients, the skin type varied between I and III, according to the Fitzpatrick 
scale. The patients were recruited from the department of Dermatology, Radboud university 
medical center, Nijmegen, The Netherlands. Skin lesions with significant hyperkeratosis, 
extensive crusts, ulcerations or lesions located on body sites that were inaccessible for the 
RCM probe were excluded. A small control group of two subjects without a skin condition was 
included to compare vascular RCM features. This study was approved by the local medical 
ethics committee and was conducted according to the principles of the Declaration of Helsinki.
RCM imaging and analysis
For navigation during RCM imaging, pictures with a lower quality than dermoscopy were taken using 
a Vivacam macro camera (Vivacam; Lucid Inc., Rochester, NY, USA). In vivo RCM imaging was 
performed using the Vivascope 1500 system (Lucid Inc.). A detailed description of this technique has 
been published previously.38, 39 Vertical mapping (Vivastack) was performed by capturing a series of 
images of 0.5 x 0.5 mm with steps of 4.5 µm in depth. The mapping started at the stratum corneum 
until the papillary dermis. Horizontal mapping of 4 x 4 mm (Vivablock) were made at different levels of 
the skin. In this study, the first appearance of nucleated cells, independent of the cell size and shape, 
was considered as the granular layer. Since the granular layer is only a few cell layers thick, two steps in 
depth below this point was considered the spinous layer. In most lesions, a movie was made at the level 
of the dermo– epidermal junction in order to visualize capillary blood flow. Images were obtained using 
Vivascan 7.0 software (Lucid Inc.). For image analysis, a list of diagnostic RCM features for AK and SCC 
was composed according to literature (Table 1).26-33, 35, RCM images were retrospectively evaluated for 
these features by an experienced RCM user (2.5 years), and a starting RCM user who was instructed 
in the basic interpretation of RCM imaging for approximately 2 weeks. Both observers were not blinded 
for the final diagnosis and evaluated the lesions systematically for the presence or absence of individual 
RCM features. Further, the mean blood vessel diameter and number of vessels per confocal image (0.5 
mm x 0.5 mm) were determined for both AK and SCC lesions. These measures were compared to the 
control group. An increased vascular dilatation was defined as a diameter of more than 5 µm and an 
increased number of blood vessel as more than 5 vessels per confocal image.
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Histopathology
Following RCM imaging, punch biopsies with a diameter of 3 mm were obtained under local 
anaesthesia with 1% xylocaine/adrenaline. After 4h fixation in formaldehyde, the skin samples 
were embedded in paraffin and thereafter sectioned and stained with haematoxylin-eosin (HE) 
for histopathological evaluation by a pathologist.
Table 1. List of RCM features for actinic keratosis (AK) and squamous cell carcinoma (SCC) with the description 
used in the evaluation and analysis of this study. This list was composed according to literature.26-33, 35, 40
RCM features Described for AK Described for SCC
Stratum corneum 
    SC disruption, detached corneocytesa x x
    Hyperkeratosisb x x
    Parakeratosisc x
    Orthokeratosisd x
    Inflammatory cellse x x
Stratum granulosum 
    Normal honeycomb patternf x
    Atypical honeycomb patterng x
    Architectural disarrayh x
    Cellular and nuclear pleomorphismi x x
    Targetoid cells 1j x
    Targetoid cells 2k x
    Multinucleated keratinocytesk x
Stratum spinosum 
    Atypical honeycomb pattern x x
    Architectural disarray x x
    Cellular and nuclear pleomorphism x x
    Targetoid cells 1 x
    Targetoid cells 2 x
    Multinucleated keratinocytes x
    Spongiosism x x
    Exocytosisn x
Dermo-epidermal junction 
    Increased blood vessel dilatationo x
    Increased number of blood vesselsp x
    Increased capillary flow x
    Lymphocyte rollingq x
Dermis 
    Solar elastosisr x x
    Inflammatory cells  x
    Keratin pearls x
    Nest-like structuret x
a  Detached corneocytes: white, highly refractive polygonal structure of approximately 30-40 µm in diameter 
in the stratum corneum. bHyperkeratosis: thickening of the stratum corneum of more than 15 µm. 
cParakeratosis: nucleated cells appearing as bright oval nuclei centrally within corneocytes in the stratum 
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corneum. dOrthokeratosis: hyperkeratosis without parakeratosis. eInflammatory cells: highly refractive structures 
of 8-10 µm in diameter. fNormal honeycomb pattern: uniform, regular spaced, broad keratinocytes forming a 
grid resembling a honeycomb. gAtypical honeycomb pattern: irregular shaped cells deviating from the normal 
honeycomb pattern. hArchitectural disarray: severe disarranged epidermal pattern in which the honeycomb 
pattern is no longer visible. iCellular and nuclear pleomorphism: variation in cellular and nuclear shape and 
size. jTargetoid cells 1: large cell with a bright centre and a dark peripheral halo. kTargetoid cells 2: large cell 
with a dark centre and a bright rim surrounded by a dark halo. lMultinucleated keratinocytes: large cells with 
tight aggregates of bright nuclei. mSpongiosis: enlargement of the bright intercellular spaces due to fluid 
accumulation between keratinocytes. nExocytosis: inflammatory cells appearing as highly refractive structures in 
the epidermis. oIncreased blood vessel dilatation: blood vessel diameter of more than 5 µm. pIncreased number 
of blood vessels: more than 5 blood vessels per 0.5 x 0.5 mm RCM confocal image. qLymphocyte rolling: 
lymphocytes in blood vessels appearing as round, highly refractive cells. rSolar elastosis: network of thick, 
highly refractive collagen bundles intermixed with moderately refractive, lace-like elastic fibres. sKeratin pearl: 
whorl-shaped accumulation of keratin appearing as highly refractive, speckled structure in the dermis. tNest-like 
structure: round, demarcated structures in the dermis that are often surrounded by fibrosis.
Statistical analysis
An univariate logistic regression analysis was performed on each individual RCM feature 
(predictor) for the diagnosis of AK, on the data set as obtained by the experienced RCM user. 
The same analysis was performed for SCC. The predictors were expressed in odds ratios (OR) 
with p-values. Predictors with a statistically significant OR (with a p-value <0.05) were evaluated 
in a forward multivariate logistic regression analysis in order to make a prediction model for 
the diagnosis of AK and SCC. The difference in blood vessel diameter and number of vessels 
per RCM confocal in SCC and AK lesions were analysed using an independent T-test. The 
interobserver agreement between the experienced observer and the starting RCM user was 
determined by kappa analysis (ĸ). The concordance was assessed by calculating the kappa 
value for each individual RCM parameter. A kappa value between 1 and 0.81 corresponded with 
an excellent interobserver agreement, values with high concordance included those features 
with ĸ = 0.8– 0.61, moderate concordance with ĸ = 0.6–0.41, poor concordance with ĸ = 
0.4–0.1 and a kappa of ≤ 0 corresponded to no interobserver agreement. All data analyses were 
conducted using computer software (SPSS Inc. version 20, Chicago, IL, USA).
Results 
A total of 30 biopsy proven lesions were evaluated with RCM, of which 24 AK and 6 invasive non-
pigmented SCC. The lesions were located on the head and neck area in 37% (n = 11), thorax in 
27% (n = 8), upper extremities in 27% (n = 8) and lower extremities in 10% (n = 3). 
RCM features for distinction between AK and SCC
Univariate logistic regression analysis resulted in statistically significant OR values for architectural 
disarray in the stratum granulosum, architectural disarray in the stratum spinosum and nest-like 
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structures in the dermis (Table 2, Figure 1). The forward multivariate logistic regression analysis 
with these parameters showed that the presence of architectural disarray in the granular layer 
would result in a correct diagnosis in 84.6% of the SCC cases. The combination of architectural 
disarray in the granular layer with architectural disarray in the stratum spinosum and/or dermal 
nest-like structures had a correct prediction of 88.5% of the SCC cases (Table 2). All other 
evaluated RCM features were not statistically significant and were therefore not able to distinct 
between AK and SCC.
Increased vascularisation in SCC and AK lesions
Comparing healthy skin with AK and SCC lesions, the mean blood vessel diameter and number 
of blood vessels per RCM confocal were increased in both AK and SCC lesions. The blood vessel 
diameter and number of blood vessels were highest in SCC. However, the vascular differences 
between AK and SCC were not statistically significant when analysed by an independent T-test 
(Table 3).
Interobserver agreement between independent observers
The interobserver agreement for the RCM parameters between an experienced and starting RCM 
user ranged from poor to no agreement. The highest concordance was reached for parakeratosis 
in the stratum corneum (ĸ = 0.33), architectural disarray in the stratum granulosum (ĸ = 0.34) 
and inflammation in the superficial dermis (ĸ = 0.36).
Table 2. RCM features for the diagnosis of SCC and AK with significant odds ratios (p-value < 0.05) based 
on the univariate logistic regression analysis. Further, the prediction model for diagnosis of SCC based on 
these RCM features is shown by the forward multivariate logistic regression analysis. 
Univariate logistic regression analysis
RCM parameter Odd ratio for diagnosis SCC Odds ratio for diagnosis AK p- value
SG architectural disarray 24.0 0.042 0.013
SS architectural disarray 15.0 0.067 0.023
DERMIS nest-like structure 11.0 0.091 0.029
Forward multivariate logistic regression analysis
RCM parameter Predicted percentage correctly 
diagnosed SCC
SG architectural disarray 84.6%
SG architectural disarray SS architectural disarray 88.5%
SG architectural disarray DERMIS nest-like structure 88.5%
SG architectural disarray SS architectural disarray DERMIS nest-like structure 88.5%
All selected parameters are shown in ascending order, according to p-value. 
SS, stratum spinosum; SG, stratum granulosum
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Table 3. Blood vessel characteristics of healthy skin and patients with squamous cell carcinoma (SCC) and 
actinic keratosis (AK)
Mean blood vessel diameter + SD (µm) Mean number of blood vessel + SD (µm)
Control   4.26 +   0.00 3.5 + 2.1
AK 13.52 +   9.89 7.8 + 4.9
SCC 27.62 + 32.251 8.6 + 4.22
1 p-value when compared to AK was 0.386 2 p-value when compared to AK was 0.739.
The mean number of blood vessels per 0.5x0.5 mm RCM confocal image.
Discussion 
RCM has been proven to be a useful, non-invasive tool for the in vivo diagnosis of melanocytic 
lesions and inflammatory skin conditions.14-16, 23-25 Further, RCM knowledge and experience in the 
field of NMSC is increasing.17-19, 22, 36 Due to often clinical similar appearance, distinction between 
SCC and AK can be challenging. Currently, the diagnostic distinction between these skin lesions, 
especially when solely based on clinical aspects, may not always be reliable. Whereas, obtaining 
biopsies is an invasive method and the feasibility is sometimes limited, mainly because of the 
risk of sampling errors. Therefore, the purpose of this study was to assess in vivo RCM features 
that are specific enough to make a distinction between AK and SCC using RCM as a non-
invasive in vivo diagnostic method.
We demonstrated that, in clinically suspicious AK or SCC lesions, the presence of architectural 
disarray in the stratum granulosum in combination with architectural disarray in the spinous layer and/
or tumour nest in the dermis were the main RCM features to distinguish SCC from AK. This result is in 
agreement with other studies that found architectural disarray in the granular layer in SCC, while the 
stratum granulosum in AK showed either normal keratinocytes or an atypical honeycomb pattern.9, 26, 
28, 32, 33, 35, 40 However, architectural disarray in the stratum spinosum was not only described in SCC but 
also in AK.9, 27, 28, 37 Therefore, architectural disarray in the spinous layer alone is not a good predictor 
for SCC. Although we found differences in the granular and spinous layer, it should be mentioned 
that it might be hard to make the distinction between the granular and spinous layer in vivo. A good 
definition of the layers and experience in RCM image analysis are required. 
The observed nest-like structures in the dermis correlate to aggregates of atypical keratinocytes 
corresponding to the diagnosis of invasive SCC. However, we also detected these nest-like structures 
in two AK lesions. This observation might have resulted from sampling error, whereby the biopsy was 
taken at a different site than where the nest-like structures were seen with RCM. This demonstrates 
the great advantage of RCM in evaluation of the total lesion, and therefore can prevent sampling 
errors. Further, we found an increased mean vascular diameter and a larger number of vessels for 
SCC and AK. Our results are in line with other studies and can be explained by the high metabolic 
needs of a tumour, which leads to vascular dilatation and neovascularisation.29, 41
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Figure 1. Representative images of actinic keratosis (AK) and squamous cell carcinoma (SCC). a) RCM 
image of AK showing a normal honeycomb pattern of the stratum granulosum. b) Atypical honeycomb 
pattern of the granular layer, visualized in an AK lesion. c) Architectural disarray of the granular layer in a 
SCC. d) Normal honeycomb pattern at the level of the stratum spinosum. e) RCM image at the level of the 
stratum spinosum, showing an atypical honeycomb pattern, which can be present in either AK or SCC. f) 
Architectural disarray of the spinous layer that is mainly observed in SCC. g and h) In SCC lesions at the 
dermal level, tumour nests (white asterisk) with surrounding fibrosis were visualized by RCM. i) Haematoxylin-
eosin stained tissue section displaying an invasive SCC nest.
AK can be categorized according to the Keratinocyte Intraepithelial Neoplasia (KIN) with 
subdivision into three histopathological grades. In KIN 1, the keratinocytic atypia is limited 
to the lower third of the epidermis, whereas in KIN II, the lower two-thirds of the epidermis is 
involved. In KIN III, including Bowens disease, cell atypia is found in the full thickness of the 
epidermis without infiltration of atypical cells into the dermis. Although Bowens disease develops 
as epidermal carcinoma in situ, it may progress into invasive SCC.4, 32, 34, 42 Therefore, it would be 
very interesting and useful to evaluate in a larger cohort whether there are specific RCM features 
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that allow distinction between KIN grades Bowens disease and invasive SCC. Despite the fact 
that RCM has some limitations in depth, this study shows that there are epidermal RCM features 
that might allow in vivo distinction between clinical similar appearing AK and SCC lesions.
The overall poor to no interobserver agreement in this study showed that RCM features for AK 
and SCC were difficult to learn and assess for an inexperienced RCM user. This illustrates the 
learning curve, which evaluation of RCM images is associated with. In contrast, the interobserver 
agreement between experienced RCM users is higher.26, 37, 43 Horn et al. showed a moderate to 
poor interobserver agreement for RCM features of AK between two dermato-oncologists with 
previous experience in RCM.26 In addition, Ulrich et al. also found a higher concordance for AK 
features among two independent experts in the field of RCM.37 However, this kind of data are not 
available for the diagnosis of SCC lesions. 
Dermoscopy is another commonly used non-invasive technique that improves the diagnostic 
accuracy of pigmented and non-pigmented skin lesions.10 Several dermoscopic features for 
AK an SCC are described,10, 11 of which some can be observed by RCM. Fraga-Braghiroli et al. 
observed with RCM the appearance of round circles with a bright white rim at the level of the 
dermo-epidermal junction corresponding to the small brown circles that can be observed with 
dermoscopy in pigmented SCC.44 Unfortunately, we were not able to confirm this observation 
since this study only revealed non-pigmented lesions. In a larger prospective study, it would be 
interesting to include pigmented lesions as well. Although dermoscopy is a useful technique, it is 
not always conclusive due to similar appearing features between AK and SCC and the limitations 
of the surface examination. Especially in these cases real-time in vivo RCM, that can image the 
skin at morphological level until the papillary dermis, is of additional value.
It needs to be mentioned that for SCC, it remains difficult to include a large number of lesions. 
The often hyperkeratotic scale of a SCC is hard to evaluate with either dermoscopy or RCM. 
However, the major advantage of both techniques cannot be found in these clinical evident SCC. 
The major challenge lies in the field of clinical similar appearing lesions and to distinct between in 
situ SCC and invasive SCC. Our goal was to evaluate these similar appearing lesions, explaining 
the unequal number included AK and SCC.
In conclusion, this study revealed specific epidermal and dermal RCM features that can distinguish 
between AK and SCC in vivo. This stimulates further prospective, large cohort investigation in 
this field, which will contribute to development of protocols, resulting in correct, efficient and 
adequate diagnosis and treatment of clinically similar appearing AK and SCC. Furthermore, 
we have shown that extensive training and experience in RCM is required in order to correctly 
differentiate AK from SCC by RCM.
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Background: Skin cancer, including basal cell carcinoma (BCC), has become a major health 
care problem. The limitations of a punch biopsy (at present the gold standard) as a diagnostic 
method together with the increasing incidence of skin cancer points out the need for more 
accurate, cost-effective and patient friendly diagnostic tools. In vivo reflectance confocal 
microscopy (RCM) is a non-invasive imaging technique that has great potential in skin cancer 
diagnosis.
Objective: To investigate whether in vivo RCM can correctly identify the subtype of BCC and to 
determine the cost-effectiveness of RCM compared to punch biopsy (usual care) in a randomised 
controlled multicenter trial.
Methods: Based on a power of 80% and an alpha of 0.05, 329 patients with lesions clinically 
suspicious for BCC will be included in this study. Patients will be randomised for  RCM or for a 
punch biopsy. When a BCC is diagnosed, surgical excision will follow and a follow-up visit will be 
planned 3 months later. Several questionnaires will be filled (EQ-5D, EQ-5D VAS, iMTA PCQ and 
TSQM-9). We will perform statistical analyses, cost-effectiveness and patient outcome analyses 
after data collection.
Results: This research started in January 2016 and is ethically approved. We expect to finish 
this study at the end of 2018.
Conclusion: In this study, we will investigate whether RCM is at least as good in identifying BCC 
subtypes as conventional pathological investigation of skin biopsies. Anticipating that RCM is 
found to be a cost-effective alternative, it saves on direct medical consumption (e.g. labour of 
the pathologist and other medical personnel) as well as materials related to treatment failure with 
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Introduction
Skin cancer is a common type of cancer and its incidence is increasing rapidly in Western 
countries.1-3 This cancer comprises two types: melanoma (MM) and non-melanoma skin cancer 
(NMSC). NMSC is further divided into basal cell carcinoma (BCC), squamous cell carcinoma 
(SCC) and its precursor lesions; actinic keratosis (AK) and Bowen disease. In the Netherlands, 
the registry of NMSC is poor. However, based on recent literature and guidelines, it is estimated 
that the incidence of malignant skin tumours and the premalignant AK is around 235,000 in 2015. 
This will have a major impact on our health care system. Moreover, it is predicted that numbers 
will rise at the rate of 4.5-8% per year, depending on the type of skin cancer. 
Currently, in case of suspicion on NMSC, the pathological examination of a punch biopsy is 
the gold standard, according to the Dutch guidelines. In case of clinical suspicion of AK, the 
diagnosis is made à vue, without pathological confirmation. Already in 2003 in the United States, 
skin cancer was found to be among the most costly of all cancers to treat. Therefore, it is evident 
that skin cancer places an enormous burden on healthcare systems with increasing costs.4 
In case of suspicion of skin cancer, it is important to diagnose and treat it in an early phase, 
preferable in a patient friendly manner. As BCC is the most common skin cancer (about 75% of 
all skin cancers), this study will focus on this type of skin cancer. 
Clinically, BCC can vary in appearance but is often characterised by small, translucent, or pearly 
papules with telangiectasias.5 In the past, the diagnosis was mainly made clinically. However, 
non-invasive therapies have become available. Therefore, determination of the BCC subtype has 
become more important. For this reason, pathological analysis of a punch biopsy is currently the 
gold standard to confirm the clinical diagnosis and determine the subtype of BCC. The following 
subtypes of BCC can be distinguished: superficial (sBCC), nodular (nBCC), aggressive BCC 
(micro-nodular (mnBCC) and infiltrative (iBCC)).6 It is experienced that there is a sample error in 
29% of the cases with the conventional diagnostic procedure, resulting in an incorrect subtype 
diagnosis.7 For this reason, and because of the increasing incidence of skin cancer, more 
accurate, cost-efficient and patient friendly diagnostic tools are desirable.
Reflectance confocal microscopy
Reflectance confocal microscopy (RCM) is a non-invasive imaging technique. It provides real 
time images of cell and tissue structures and in vivo dynamics, without the need for ex vivo 
tissue samples. RCM visualises human skin up to a depth of around 250 µm.8-12 Refractive index 
differences between cells and surrounding tissue provide the contrast. The contrast of RCM 
imaging of the skin is mainly provided by melanin and keratin.10 Most, but not all tumours can 
be visualised. For thicker tumours, RCM may help to find the optimal localisation to perform a 
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biopsy, as superficial features in these tumours may help to spot these lesions.13 Moreover, RCM 
can image the whole tumour. 
RCM features for NMSC have been described and showed a high correlation with conventional 
histopathological features.13-15 These features aid in diagnosing AK and SCC, and BCC.13-15 For 
the nodular and micronodular BCC subtypes, the following RCM characteristics are described: 
tumour nests with peripheral palisading, branch-like structures, fibrotic septa and increase of 
vascular diameter. The size and shape of the tumour nests allow further distinction between 
these BCCs. Solar elastosis and tumour nests connected with the basal cell layer characterise 
sBCCs.14 Infiltrative BCCs are more challenging to visualise due to their histological complex 
appearance and deeper location.16
Only few studies report data on the diagnostic accuracy of RCM for a primary BCC diagnosis. 
14,16-19 These studies show a high sensitivity and specificity for RCM as a diagnostic tool for 
BCC. Although they show the potential of RCM in the diagnosis of BCC, prospective large-scale 
studies are lacking. Furthermore, no diagnostic accuracy data is reported on determining the 
BCC subtype using RCM. These kind of studies are required for implementation of RCM in the 
routine patient care and incorporation into the health insurance system. Implementation of RCM 
in the routine patient care settings has the advantage of diagnosis a BCC at the first consultation 
and therefore, the patient can be treated at a short term. A second consultation for explaining the 
diagnosis and performing the treatment might be unnecessary. Therefore, time saved by using 
RCM can be used for other new patients. 
Objectives
The primary objective of this study is to investigate whether in vivo RCM can identify the BCC 
subtype at least as correct as a skin punch biopsy. We hypothesise that RCM imaging allows 
correct identification of the BCC subtype (nBCC, mnBCC, sBCC, iBCC and mixed type BCC), 
and true and false positive results are equal compared to conventional pathological investigation 
of skin biopsies (gold standard). It is postulated that RCM is more cost-effective and patient 
friendly compared to the current procedure. Therefore, the quality of life (Qol), costs and quality 
adjusted life years (QALY’s) will be evaluated as secondary outcome measures. Overall, with 
implementation of RCM in dermatological skin cancer care, it is aimed to contribute to cost-
effective, non-invasive and patient friendly diagnostic methods.
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Methods
Recruitment, inclusion and study design
Patients with lesions clinically suspicious (diagnosis à vue) for BCC, eligible for RCM, visiting the 
dermatological departments of the Radboud university medical center, Nijmegen; the Canisius 
Wilhelmina Hospital, Nijmegen; and the Rijnstate Hospital Arnhem-Velp, in The Netherlands will 
be asked to join this study.
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
 • Patients must be 18 years old and above.
 • Patients must be able to adhere to all requirements of the study.
 • Patients must be willing to give written informed consent.
 • There must be a clinical diagnosed or clinical suspicion of a basal cell carcinoma.
A potential subject who meets any of the following criteria will be excluded from participation in 
this study:
  •  Patients who currently participates in another investigational research or has been in 
the previous 28 days before the study.
 •  Patients having a medical condition which excludes participating in the study, 
according to the investigator.
 •  Incapacitated subjects.
 •  Subjects with lesion(s) on parts of the body that do not allow adequate imaging of the 
tumour with RCM.
When a patient meets these criteria and has given informed consent, he or she will be assigned 
to a randomisation arm according to a computer-generated block randomisation using Castor 
EDC, CIWIT B.V., Amsterdam, The Netherlands (Figure 1). 
Power calculation 
The primary outcome in this study is the percentage of correctly identified BCC subtypes after 
excision (gold standard in this study). We assume that this is 71% when a biopsy is used and 
85% when RCM is used (based on an ongoing study). In this case, 148 patients are needed per 
group to obtain a power of 80% (Fisher-exact, two-sided, alpha=0.05). We expect that 10% of 
the patients with a clinically suspected BCC will not have a histopathologically confirmed BCC. 
Therefore, we will include approximately 329 patients with a clinical suspicion of BCC. In this 
multicenter randomised controlled trial (RCT), it is also possible to obtain empirical estimates 
on the (cost-)effectiveness in the daily clinical practice. The expected benefit of the RCM is 
anticipated at 92 euro per patient. Based on a conservative choice of the SD of 100 euro and 
the CI of 95%, 146 patients per group are required. Counting a 10% possible dropouts, around 
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322 patients need to be included. To answer both questions, a total of 329 patients with a clinical 
suspected BCC will be included in this study.
Figure 1: Randomisation procedure. Two randomisation arms are designed. After inclusion, a patient with 
a clinical diagnosis of BCC (diagnosis à vue) will be randomised over two arms. One arm contains the 
standard procedure of a skin punch biopsy, the other arm contains the diagnostic tool to be investigated, 
RCM. A punch biopsy will also be obtained when there is no suspicion of a BCC using RCM.
Outcome measures
The primary outcome measure is defined as correct subtyping of the BCC after excision. The 
histopathological diagnosis of the excision specimen will be compared to the diagnosis made by 
RCM or by punch biopsy. Secondary outcome measures are QoL, cost and QALY’s.
Procedure
Patients will be assigned to either the RCM or the biopsy study arm (Figure 1). When a BCC is 
diagnosed using RCM or a punch biopsy, surgical excision will follow according to standard care 
time schedule at the centre where the BCC is diagnosed with margins according to the Dutch 
guidelines (3 mm for sBCC, 5 mm for aggressive BCC subtypes). In case of a BCC diagnosis, 
a follow-up visit will be planned 3 months after surgery. In the absence of a BCC diagnosis, 
based on either RCM or a punch biopsy, the patients will again be followed up after 3 months. 
During visit 1 (diagnostic procedure) several questionnaires will be filled (EQ-5D, EQ-5d VAS, 
iMTA PCQ and TSQM-9). At the follow-up visit (after treatment), the questions about satisfaction 
of the diagnostic procedure will be asked again. In order to establish the added monetary value 
of RCM, a contingent valuation method (CVM) was used. Patients that belong to the RCM arm 
but also had a punch biopsy, and in which both times no BCC was observed, were interviewed 
according to the CVM.
RCM will be performed using the commercially available Vivascope 1500 (Caliber Imaging & 
Diagnostics, Rochester, NY, USA) according to a standardised protocol. Vivablocks of 4 x 4 mm 
will be made at the level of the stratum corneum, stratum spinosum, dermo-epidermal junction 
and dermis in order to find RCM features for BCC and the subtype. Vivastacks will be made in 
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the areas of interest. Movies will be made to document vascularisation. When indicated, the 
Vivascope 3000 handheld device will be used. The RCM user is working for 4 years with the 
device. If a punch biopsy needs to be obtained according to the randomisation scheme, this 
will occur after local anaesthesia (1% Xylocaine/Adrenaline) and the punch biopsy will have a 
diameter of 3 mm. The punch biopsy will be taken from the most clinically suspected area of the 
lesion.
Statistical analysis
After data collection, statistical analyses will be performed. The Fisher’s-exacts test will be used to 
test the differences in the primary outcome between the two study arms (punch biopsy, RCM) for 
statistical significance. Multivariable logistic regression will be used to study possible differences 
between the subtypes and the effects of possible other variables. This will be performed in order 
to evaluate variables or sets of variables for its discriminative character that can be used to 
develop protocols and guidelines for future RCM users in the Netherlands.
Cost-effectiveness analysis
The cost analysis comprises two main parts. First, on patient level, volumes of care will be 
measured prospectively over the time path of the clinical trial using the iMCQ (a generic instrument 
for measuring medical costs 20) complemented with procedure specific cost information like cost 
of RCM equipment and patient out-of-pocket expenses, such as over-the-counter drugs (e.g. 
pain related). Relevant, (missing) entries will be verified or completed by data from the medical 
records or inpatient treatment facility’s administration system. Second, per modality (RCM or 
usual care) standard cost prices will be determined using the Dutch guideline 21 or else real/full 
cost prices via activity-based costing. Productivity losses will be estimated using a patient-based 
questionnaire. 22 The friction cost-method will be applied following the Dutch guidelines.21
Patient outcome analysis
The effect analysis adheres to the design of an equivalent RCT and measures diagnostic 
performance and QoL at baseline and at fixed points along the follow-up of the RCT. To measure 
the quality of the health status of the patients, a validated so-called health-related quality of life 
(HRQoL) instrument will be used, the EuroQol-5D-3L (EQ-5D).23 This HRQoL instrument will be 
completed by the patients and is available in a validated Dutch translation.24 The EQ-5D is a 
generic HRQoL instrument comprising five domains: mobility, self-care, usual activities, pain/
discomfort and anxiety/depression. The EQ-5D index is obtained by applying predetermined 
weights to the five domains. This index gives a societal-based global quantification of the 
patient’s health status on a scale ranging from 0 (death) to 1 (perfect health). Patients will also 
be asked to rate their overall HRQoL on a visual analogue scale (EQ- 5D VAS) consisting of a line 
ranging from 0 (worst imaginable health status) to 100 (best imaginable). The patient outcome 
116
CHAPTER 3.3
analysis will be complemented with a CVM questionnaire and measures of satisfaction and pain 
related to diagnosing subtype BCC.
Results
This investigator initiated RCT is conducted according to the principles of the Declaration of 
Helsinki (2013) and in accordance with the medical Research Involving Human Subjects Act 
(WMO). The study is funded by ZonMw, a Dutch organisation that finances health science, and 
thereby, stimulates the use of obtained knowledge to improve healthcare. The medical ethics 
committee approved the study protocol in December 2015 (NL 54549.091.15). The study will 
start in January 2016, and is expected to finish at the end of 2018. This trial had also been 
registered at ClinicalTrails.gov (nr: NCT02623101).
Discussion
Considering the increasing skin cancer problem, including BCC, and the disadvantages of 
the current diagnostic gold standard, histopathological diagnosis of a punch biopsy, there is 
a need for more cost- and time-efficient diagnostic tools with a high accuracy for diagnosing 
skin malignancies. These tools should be able to distinct between different skin cancer types 
and should be able to determine the correct BCC subtype, as different subtypes of BCCs are 
treated differently. Punch biopsies often result in sampling errors, as only a small part of the 
tumour is investigated, resulting in potentially inappropriate chosen therapies. As a sample error 
may lead to treatment failures or recurrences, other subsequent treatments are needed. This 
will eventually lead to increasing costs. In addition, the conventional method is unfriendly for 
patients, as it is invasive, painful and might result in scarring. Furthermore, the diagnosis cannot 
be made instantly.
To contribute to implementation of RCM as a non-invasive skin cancer diagnostic tool, this study 
will investigate whether RCM is at least as good in identifying BCC subtypes as conventional 
histopathological investigation of skin biopsies. Hypothesising that RCM is a cost-effective 
alternative to the present care, it saves on direct medical consumption like labour of the 
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4.1
The value of (video)dermoscopy 
in the diagnosis and monitoring of 
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Clinical diagnosis of inflammatory skin disorders (ISD), including hair and nail disorders, is 
not always straightforward. Not uncommonly, a punch biopsy is required. Dermoscopy and 
videodermoscopy (VD) are non-invasive techniques that are used for in vivo examination of the 
skin, hair and nails. Both techniques can contribute to determining the accurate diagnosis and 
can be promising in assessing the treatment effects. We systematically searched and reviewed 
the current published literature on ISD evaluated by dermoscopy and VD in the electronic 
databases PubMed, Embase, Cochrane Library and Web of Science. All studies were assessed 
for their quality using the Strengthening the Reporting of Observational studies in Epidemiology 
and Cochrane checklist. Finally, 82 studies were eligible for inclusion. An overview is presented 
of the (video)dermoscopic features for common ISD diagnoses, with the corresponding 
accuracies, and monitoring features for treatment effects. Although, (video)dermoscopy is a 
promising technique, studies of high methodological quality are necessary to evaluate the value 
of VD over conventional dermoscopy in common ISD. 
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Introduction 
The need for more objective evaluation of the skin within the dermatology is increasing. 
Dermoscopy is a simple and affordable non-invasive imaging technique that suits the need 
for more objective dermatological features. It generally allows 10x magnification, offering the 
possibility to assess skin structures in more detail and is gaining increasing importance in the 
diagnosis and monitoring of skin diseases. The many improvements in digital camera and 
computer technology between 1980 and 2000 have led to the development of digital VD.1 VD is 
performed by a video camera equipped with optic fibers and lenses that allow high-resolution 
imaging at magnifications up to 1000x. The images obtained are visualised on a monitor and 
can directly be stored digitally, to identify and compare changes over time.2 VD allows higher 
magnification, compared to conventional dermoscopy, which potentially offers visualisation of 
more specific features. However, there is a lack of studies comparing these two techniques.3,4  
Currently, dermoscopy is used more often in the daily clinical practice than VD, mainly in the 
evaluation of neoplastic lesions, including melanoma and non-melanoma skin cancers.5,6 In 
contrast, inflammatory skin diseases (ISD), including hair and nail disorders, have been studied 
less frequently by dermoscopy. Moreover, there is scarce knowledge on the possible additional 
value of VD, compared to dermoscopy. 
Clinical diagnosis of ISD can sometimes be difficult. In these cases histopathology can contribute 
to the accurate diagnosis. However, biopsy is an invasive method with risks of developing local 
inflammatory reactions and scar tissue with a possibility of sampling errors and the inability to 
follow dynamic processes over time. Furthermore, a biopsy is unfavourable in the facial area in 
which ISD are often localised.7 Therefore, in general, the clinical diagnosis of ISD is the leading 
factor in many cases. This means that diagnostic uncertainty is often accepted, resulting in 
therapeutic uncertainty. Dermoscopy has shown to aid in assessing the clinical diagnosis of ISD.8 
Moreover, dermoscopy might be promising in assessing the treatment effects.2 As dermoscopy 
and VD are both non-invasive and patient friendly techniques, they are preferred over invasive 
methods. This makes them interesting techniques for daily use in the clinical setting. 
A systematic review on both VD and dermoscopy is essential for an objective evaluation of 
the current literature in order to facilitate the increasing use of both techniques in the daily 
clinical practice. Furthermore, the value of VD over conventional dermoscopy can be assessed. 
Therefore, current literature was evaluated for the following purposes:
 i    To present an overview of the most prevalent ISD, including hair and nail disorders, 
that can be evaluated by dermoscopy and/or VD.
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 ii    To assess diagnostic and monitoring features of dermoscopy and VD, including the 
accuracy.
 iii To evaluate the current value of VD over conventional dermoscopy in ISD.
Methods
A systematic literature review following the PRISMA statement checklist9 was conducted in four 
electronic databases: PubMed, Embase, Cochrane Library and Web of Science. The search was 
based on dermoscopy, VD and a list of all relevant synonyms. ISD included a broad spectrum of 
diagnoses, requiring a systematic approach based on the classification scheme of inflammatory 
dermatological disorders by Billings et al.10 The focus of this review lies in the applicability 
of dermoscopy and VD in the most prevalent ISD with a primary inflammatory component. 
Publications on oral and genital dermatoses, genodermatoses, vascular diseases, pigmentary 
diseases, infections and infestations, non-cicatricial alopecias or studies focusing exclusively 
on (video)dermoscopy of hair shafts were excluded. Publications on (video)capillaroscopy were 
also excluded, because this specific tool is solely used for the visualisation of the microcirculation 
whereas (video)dermoscopy can be used for viewing a broader range of features. We included 
several bullous dermatoses with a genetic origin and cicatricial alopecias. 
The search was restricted to publications on humans and the English, German and Dutch language. 
All published studies until the date of 03.10.2016 were included (Supplementary table 1). After the 
initial search, titles, and when necessary abstracts and/or materials and methods were screened 
(MHEV). After this selection, two reviewers (MHEV and MP) independently screened titles and 
abstracts according to a checklist specifying inclusion and exclusion criteria. Where the abstract 
was unavailable, full-text articles were screened for specific criteria and if relevant retrieved for further 
evaluation. Subsequently, the full texts were critically assessed for their eligibility by two reviewers 
(MHEV and MP). Differences in assessment between the two reviewers were either resolved by 
consensus or discussed with a third reviewer (KPN). Studies had to fulfill the following three criteria 
for inclusion: (i) the use of (video)dermoscopy; (ii) description of ISD features and (iii) description of 
(video)dermoscopy features. Abstracts with unavailable full texts, articles concerning skin diseases 
different from ISD according to Billings et al.10 and papers regarding other imaging techniques were 
excluded. Excluded papers were reviews, editorials, opinions, ex vivo or animal studies. To ensure all 
relevant studies were included, the reference lists of all included articles for the full text screening were 
checked for additional relevant studies not identified by the initial search.
The final selected articles were evaluated for the following study characteristics; type of ISD, 
study design, number of participants, number and localisation of evaluated lesions, aim of the 
study, used technique (dermoscopy or VD), (video)dermoscopic features, their accuracy and the 
reference test to (video)dermoscopy. 
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Methodological quality of the included studies was assessed using the STrenghtening the 
Reporting of OBservational studies in Epidemiology (STROBE) criteria.11 This scale was modified 
to assess the quality of case reports and case series by exclusion of the terms ‘variables’ and 
‘study size’. Studies are classified by three categories. Category A was defined as fulfilling > 
80% of the STROBE criteria, category B as 50-80% and category C as < 50% of the STROBE 
criteria. Randomised controlled trials (RCTs) could not be evaluated using the STROBE checklist, 
and were assessed using the Cochrane checklist.
Results
In total, 13.978 articles were found after the literature search (Figure 1). This total consisted of 9489 
unique titles that were assessed for further screening. The first screening process identified 983 
articles concerning in vivo (video)dermoscopy of the skin. The screening of the two reviewers showed 
an overlap of 98% and resulted in the inclusion of 193 articles that were eligible for full-text screening. 
Twenty-four full texts were unavailable and 87 articles did not met the inclusion criteria. The full-text 
screening had an overlap of 100% between the two reviewers. The additional check of the reference 
lists of the included studies did not result in the selection of additional valuable articles.
Figure 1. Flow chart: selection process of included studies. 
Eventually, 82 publications were included. Table 1 provides an overview of the ISD categories and 
number of included studies. Ten studies were included in several categories as they described 
multiple inflammatory diagnoses.7,12-20 There were 12 articles on videodermoscopy (Table 
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2)12,16,18,21-29, 68 articles concerning dermoscopy (Table 3)7,13-15,17,19,20,30-90 and 2 studies using both 
dermoscopy and VD (Table 2 and 3).91,92 Four studies presented monitoring features23,39,58,63, 
whereas 73 articles had a diagnostic aim.7,12-22,24-28,30-38,40-57,59-62,64-71,73-82,84-86,88,90-92 Five articles 
described both diagnostic and monitoring features.29,72,83,87,89 
Table 1. Category and number of included studies
Spongiotic dermatitis (n = 11)*
Pityriasis rosea17,19,56
Various forms of eczematous/erythematous dermatitis (allergic and contact dermatitis, atopic dermatitis, seborrheic 
dermatitis, chronic hand eczema, drug rashes, erythema multiforme and annular erythema).7,13-19,57,58





Interface dermatitis (n = 11)*
- Lupus erythematosus (cutaneous) and lichen planus12,14,17,19,20,67-72
Perivascular dermatitis (n = 2)*
- Common urticaria19,30
Nodular and diffuse dermatitis (n=4)*
- Sarcoidosis (cutaneous) 7,19,31,32
Pallisading granulomatous dermatitis (n = 5)*
- Granuloma annulare and necrobiosis lipoidica19,33-36
Sclerosing dermatitis (n=16)*
Morphea/scleroderma (systemic sclerosis) 19,28,37-44,53,54
Lupus (systemic lupus erythematosus) 19,38
- Lichen sclerosus (extragenital) 43-48
Bullous dermatitis (n = 8)
- Darier’s disease, dermatitis herpetiformis, pemphigus and pemphigoid and variants, Grover’s 
disease19,26,49,50,73-75,90
Alopecia (cicatricial) (n = 20)*
- Frontal fibrosing alopecia, discoid lupus erythematosus, lichen planopilaris, central centrifugal cicatricial 
alopecia, folliculitis decalvans, alopecia mucinosa, pseudopelade of Brocq.7,18,22,24,27,51,76-88,91
Miscellaneous inflammatory and reactive disorders (n = 2)*
- Rosacea7,89
Total n = 82
Most included studies in this review were case reports (n=25) and case series (n=15), followed 
by cross-sectional studies (n=35),  cohort studies (n=4), case-control studies (n=2) and 
RCT (n=1). The methodological quality assessment identified that 72% (59/82) studies were 
classified as category C and the remaining  28% (23/82) were classified as category B (Table 2 
and 3). The majority of the studies lacked description of the setting, variables, potential sources 
of bias, description of statistical methods and generalisability. We included one RCT that had 
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a moderate quality according to the Cochrane checklist. An overview of the most frequently 
described features of all included ISD is given in Table 4. Because of the extensive spectrum of 
imaged ISD, four common ISD, of which the (video)dermoscopic accuracy was available, will be 
discussed in detail.
Plaque type psoriasis
Eight studies revealed VD features for diagnostic and monitoring applications in 
psoriasis.12,16,18,21,23,25,29,92 The most observed VD features were arborising, torturous, glomeruli-
like or ‘bushy’ capillaries.12,16,18,23,25,29 The majority of the studies (n=13) used dermoscopy to 
evaluate psoriasis.13-15,17,19,20,52,55,59-63 Using dermoscopy, the most observed vascular features 
were homogeneous red dots and globules, red lines and  twisted red loops. Although present 
in every psoriatic plaque, red dots are not a specific dermoscopic feature for psoriasis, as they 
can also be found in other papulosquamous dermatoses. However, the uniform, symmetrical, 
regular distribution of these red dots throughout the lesion is suggestive for psoriasis.17 When 
the presence of marked hyperkeratosis impedes the view of underlying dermoscopic features, 
scale removal may be useful to display the above-mentioned vascular pattern and possible 
tiny red blood drops (“Auspitz sign”).62 Vazquez-Lopez et al.20 showed a 100% sensitivity for the 
feature red globules in the differentiation of plaque psoriasis (PP) and lichen planus (LP). Pan 
et al.55 introduced a dermoscopic diagnostic model for the differentiation of solitary psoriatic 
plaques from intra-epidermal carcinoma and superficial basal cell carcinoma. They concluded 
that red dots, homogeneous vascular pattern and light red background were significant 
dermoscopic features for psoriasis, yielding a diagnostic probability of 99% if all three features 
were present.  Lallas et al.17 showed a diagnostic sensitivity of 84,9% and specificity of 88,0% for 
the combination of regularly distributed dotted vessels over a light-red background associated 
with diffuse white scales. Several studies showed the monitoring capacity of (video)dermoscopy 
to examine therapeutic effect.23,29,63 Overall, both dermoscopy and VD can be considered as a 
diagnostic and monitoring tool in psoriasis. 
Lichen planus
Videodermoscopic imaging of LP was described in one study12, whereas 9 studies used 
conventional dermoscopy.14,17,19,20,67,68,70-72 With VD, wickham’s striae can be observed.12 The most 
described dermoscopic features for LP include radial capillaries or red lines and Wickham’s 
striae. Wickham’s striae are described as round, linear, reticular or annular pearly-whitish 
structures and may develop thin or broad arboriform projections, surrounded by dotted or linear 
vessels that highlight them.17,71 Wickham’s striae correspond histopathologically to compact 
orthokeratosis above the zones of wedge-shaped hypergranulosis.20 Vazquez-Lopez et al.20 
showed a 92% sensitivity of Wickham’s striae in the diagnostic differentiation of LP and PP. 
Furthermore, dermoscopy is able to discriminate between two types of hyperpigmentation in 
LP: a brownish diffuse pattern, that is probably related to pigmentation in the epidermis, and a 
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deeper grey blue dotted pattern, which corresponds to pigment in dermal melanophages.12,72 
These features have potential prognostic value, as lesions with the largest numbers of blue dots 
seem to be more persistant.72 
Systemic sclerosis 
Dermoscopy and VD are used to visualise vascular features of systemic sclerosus (SSc) in 
the nailfolds. Seven studies of low to moderate methodological quality were included, of which 
one research group used VD to evaluate SSc.28,37,38,40,42,53,54 Videodermoscopy showed dilated 
capillaries, nailfold bleeding and avascular areas.28 The most important dermoscopic features are 
similar to the features observed by VD. These findings confirm clinical suspicion of SSc justifying 
further investigation. Muroi et al.54 revealed a sensitivity and specificity of resp. 83,1% and 100% 
for the presence of two or more enlarged capillaries in one or more fingers. Ohtsuka et al.28 
showed that the distribution of dilated capillaries and/or nail fold bleeding in SSc was significantly 
elevated compared to the normal controls, with a sensitivity of 40.8% and specificity of 93.5% 
respectively. Mazzotti et al.53 showed a sensitivity and specificity for the scleroderma pattern 
(occurrence of avascular areas and/or the presence of dilated capillaries) using dermoscopy. 
The authors also concluded that these results are comparable to traditional capillaroscopy. In 
general, dermoscopy allows a fast and feasible recognition of vascular abnormalities of the 
nail fold. Moreover, it offers a promising alternative to more expensive and complicated (video)
capillaroscopy that is not widely available.42,53
Cicatricial alopecia
Dermoscopy and VD are widely used in the evaluation of hair and scalp disorders. Five studies 
described VD features for different primary cicatrical alopecias (PCA).18,22,24,27,91 Sixteen studies 
used dermoscopy to evaluate PCA.7,24,51,76,78-88,91 The main VD and dermoscopic feature of 
cicatricial alopecia is the reduction or absence of hair follicles.18,22,51,80,81,84-88,91 Abedini et al.51 
showed that the presence of non-follicular red dots, enlarged and tortuous branching vessels, 
follicular keratotic plugging, speckled pigmentation, perifolliculair erythema, peripilar white halo, 
and hair tufting had 100% specificity for the diagnosis of PCA. There are (video)dermoscopic 
features that may help dermatologists to differentiate between non-cicatricial alopecia and 
PCA.18,51,80 Furthermore, (video)dermoscopy shows promising features in the monitoring of 
treatment effects in scalp disorders.87,93
Value of videodermoscopy (VD)
With VD, more specific and detailed features can be visualised compared to dermoscopy due 
to the higher magnification. In psoriatic lesions, low magnification (10x) by dermoscopy shows 
the presence of a red-dotted pattern. However, using VD with a higher magnification (100-400x), 
typical elongated and convoluted ‘bushy’ capillaries can be detected that are homogeneously 
distributed within the plaque.16,25 Unlike dermoscopy, VD was also able to visualise dilated, 
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tortuous, elongated, and irregular distributed capillaries in the hyponychium of nail psoriasis 
patients.29 After treatment, a significant reduction in the number of visible capillaries was seen 
with the VD. Therefore, VD can also be used to monitor treatment effects.
Discussion
Dermoscopy is a well-established technique used within dermatology, mainly in dermato-oncology. 
However, its indications has expanded to include e.g. scalp and hair diseases93,94, nail and nail 
fold abnormalities95,96 and inflammatory and infectious skin diseases.8,97,98 Videodermoscopy is 
relatively ‘modern’ in this field with multiple benefits over ‘common’ dermoscopy and therefore 
gaining more interest. (Video)dermoscopic features of various ISD are widely described and, in 
a lesser degree, they are used to describe the follow up of treatments. However, the spectrum of 
ISD is extensive. Therefore, there is a need for a systematic review to address the current value 
and applications of both VD and dermoscopy in common ISD.
This review presents the broad application of (video)dermoscopy in common ISD. However, 
the methodological quality of the included studies is relatively low. There were 9 studies 
describing the sensitivity and specificity of dermoscopic features in diagnosing ISD. They show 
that dermoscopy is promising in aiding the clinical diagnosis of ISD. An advantage of VD is 
the availability of multiple magnifications, which makes it a promising technique to evaluate 
more specific and detailed features compared to dermoscopy.16,25,29 Though, more studies of 
high methodological quality on VD is recommended to determine its value over conventional 
dermoscopy. These studies should also address attention to the interobserver variability, and 
level of training, which is currently sparsely reported 37,42  
Although costs of VD are higher compared to dermoscopy, the use of this technique might 
contribute to standardisation of dermoscopic imaging. Compared to dermoscopy, VD is less 
influenced by external factors, such as environmental light. Colours can be calibrated, maintaining 
the same environmental conditions which  can lead to obtaining more reproducible images.99 
This can enhance the clinical judgment, in particular in the monitoring of lesions. 
Recent development has led to development of software programs that quantify geometric and 
colorimetric parameters of videodermoscopic images. They introduce an objective element to 
the diagnosing making process, and can therefore be an useful tool, particular for clinicians 
(dermatologist as well as general practitioners) with minimal training in dermoscopy.100-102 
Moreover, quantitative assessment, using computer programs, can be useful in the monitor of 
treatment effects.29 Using VD, the skin images are directly visualised on a monitor which can be 
used as a didactic modality to patients and students, aiding in the explanation of skin diseases 
to others. Moreover, VD can overcome the embarrassment that may occur in some cases during 
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dermoscopic examination when there is close contact between the dermoscopist’s head and 
patient’s skin surface. 
In conclusion, this systematic review provides an overview of ISD imaged by (video)dermoscopy. 
(Video)dermoscopy is a promising tool for diagnosing and monitoring common ISD. However, 
as dermatological imaging is developing quickly, it is important to evaluate the value of VD over 
conventional dermoscopy. Therefore, it is recommended to perform more research on VD or 
comparative studies on VD and dermoscopy in common ISD.
131
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Table 4. Overview of frequently described (video)dermoscopic features in the diagnosis of all included 
inflammatory skin diseases
Skin disorder (Video)dermoscopic features
Pityriasis rosea Yellowish background, peripheral white scales (collarette scaling), dotted 
vessels with patchy distribution
Dermatitis (eczematous, morbilliform, 
atopic, contact)
Dotted vessels with patchy distribution, yellow scales
Psoriasis Homogeneous red dots and globules, red lines and  twisted red loops, 
white scales and a light-red/dull background 
Pityriasis rubra pilaris Round/oval yellowish areas, whitish keratotic plugs with a yellow 
peripheral keratotic ring
Prurigo nodularis White starburst pattern, scales, crusts and erosions, follicular plugging, 
dotted/glomerular vessels
Lichen simplex chronicus Erythematous background, scales and hair breakage: broom hair fibers
Lupus erythematosus (cutaneous) Homogeneous red lines, red background
Lichen planus Wickham striae, peripheral dotted/linear vessels, grey-blue dots and grey-
blue background
Common urticaria Network of linear vessels surrounding avascular areas
Sarcoidosis (cutaneous) Orange-yellowish globules or areas and linear vessels
Granuloma anulare Dotted and/or linear vessels with a white, red or yellow background
Necrobiosis lipoidica Prominent network of linear arborizing vessels and a yellowish background 
Morphea Fibrotic beams and linear vessels
Systemic sclerosis Dilated and giant capillaries, loss
of capillaries, hemorrhages and avascular areas
Systemic lupus erythematosus Twisted unenlarged capillaries and extravasates
Lichen sclerosus White/yellowish structureless areas, yellowish keratotic plugs, scales and 
comedo-like openings
Darier’s disease Pseudocomedones, erythema, dotted/linear vessels
Dermatitis herpetiformis Erythematous and violaceous dots, erythematous and brown dots
Pemphigus Extravasations, yellow hemorrhagic crusts, linear serpentine vessels and 
glomerular vessels, whitish halo
Grover’s disease Star-like (stellate) pattern, linear/irregular vessels and dotted vessels
Frontal fibrosing alopecia Reduced follicular ostia, perifollicular scales, perifollicular erythema and 
branching capillaries
Discoid lupus erythematosus Arborizing red lines,  hyperkeratotic perifollicular white scales and an 
absence of follicular ostia
Lichen planopilaris Simple red loops, arborizing red lines, honeycomb pigment pattern, white 
dots and scales, absence of follicular ostia
Central centrifugal cicatricial alopecia Honeycomb pigmented network, peripilar white/gray halo, white patches 
and dots, scales
Folliculitis decalvans Simple and twisted red loops, arborizing red lines, white dots and scales 
and an absence of follicular ostia
Alopecia mucinosa Patulous follicular openings
Pseudopelade of brocq Lack of follicular ostia without any other specific findings
Erythematotelangiectatic rosacea Polygonal vessels
Papulopustular rosacea Follicular plugs, follicular pustules and polygonal vessels
169
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Morphological characterisation of the skin plays an important role in establishing the diagnosis of 
a skin lesion and for monitoring treatment responses. In case a clinical diagnosis is challenging, 
histopathological evaluation of a skin biopsy is the gold standard. However, a skin biopsy is 
an invasive diagnostic procedure, which can result in scarring and inflammation. In addition, 
it hinders the ability to monitor dynamic processes over time and is prone to sampling errors. 
Sampling errors can occur due to sampling of an inappropriate site within a heterogeneous lesion. 
Moreover, it may also occur when the most aggressive or active part within a punch biopsy is 
missed during histopathological examination. Subsequently, sampling error can lead to under-, 
mis- or non-specific diagnoses and inadequate treatment. In recent years, non-invasive imaging 
techniques have been developed to evaluate the morphology of the skin in more detail. Among 
these techniques, reflectance confocal microscopy (RCM) and videodermoscopy (VD) offer the 
possibility to examine the skin at a high resolution. By using these techniques, the diagnostic 
accuracy can be improved without the need for invasive skin biopsies. Overall, the objective of 
this thesis was to adjust current protocols in order to optimise the diagnostic process and to 
explore the morphology of the skin using advanced imaging techniques. 
Aim 1: To investigate the sampling error in superficial basal cell carcinoma 
and its clinical effect 
Basal cell carcinoma is the most common malignancy in the Caucasian population, emphasizing 
the importance of its diagnosis and treatment.1 Histological subtyping of BCC is essential, as 
sBCC can be treated with non-invasive treatments while aggressive BCCs (mnBCC and iBCC) 
require a larger surgical margin compared to nBCC. European guidelines recommend a punch 
biopsy in clinically suspicious BCC.2 However, in 11% to 39.1% of the cases, a punch biopsy 
failed to identify an aggressive BCC subtype correctly.3-5 This may be due to sampling error of 
a punch biopsy.  In Chapter 2.1 the sampling error within primary punch biopsies, that were 
diagnosed as sBCC, is addressed. The accuracy of the current histological examination process 
(evaluation of one level only) was compared to a more extensive step-section method (evaluation 
of 5 levels within a punch biopsy). Assessment of 5 levels resulted in 22.4% detection of other 
BCC subtypes (nBCC, mnBCC en iBCC). This study showed that histological examination of only 
one level within a punch biopsy leads to underdiagnosis of other BCC subtypes. However, the 
procedure of sectioning, staining and evaluation of 4 additional levels is more labour intensive, 
time consuming and costly compared to the current method. Therefore, a protocol which is 
less intense, but still yields a high detection of more aggressive BCC subtypes, is preferable. 
Alternative protocols can consist of evaluation of 2 addition levels (sections at 400 µm and 800 
µm deeper then the initial H&E stained section) or one additional level (one section at 800 µm 
deeper then the initial H&E stained section), yielding detection rates of other BCC subtypes 




biopsies are obtained from clinically difficult to diagnose inflammatory skin diseases. These 
biopsies are, thereafter, cut in the middle and evaluated at 2 levels. This protocol provides a 
larger sample size and is less time consuming for the pathologist compared to the examination 
of 5 levels. However, these 2 levels are both sectioned near the cut in the middle and are, 
therefore, located very close together. This does not offer a broad overview of the punch biopsy. 
For that reason, this method is not an appropriate alternative for histological investigation of a 
punch biopsy suspicious for BCC. In addition, BCCs most frequently occur in the facial area 
where a larger punch biopsy is not favoured due to the risk of a larger scar. In the present 
study, clinical recurrences and treatment failures to non-invasive treatments were only seen in 
a small number of the biopsied lesions, most probably due to a short follow-up time. The follow 
up period in our study was less than a year, whereas sBCC recurrences are reported up to 3-4 
years post-treatment.6-8 Therefore, we plan to extend our follow up period in order to investigate 
whether the detection of a more aggressive BCC subtype is associated with a higher number of 
recurrences.
MAL-PDT is considered to be a non-surgical treatment option for sBCC with good cosmetic 
outcome.9 The current European MAL-PDT protocol consists of 2 treatment sessions one week 
apart and to be repeated at 3 months if required. This protocol requires at least 2 hospital visits, 
which is costly and unpractical for patients. In chapter 2.2 a pilot study on the clinical efficacy 
of two MAL-PDT illumination schemes on the same day in sBCC is described. It was shown 
that MAL-PDT, using 2 illumination sessions on the same day, shows promising results in the 
treatment of sBCC. Interestingly, 5 clinical treatment failures and recurrences were noted, of 
which 3 appeared to be mixed types BCCs in the excision specimen. This is caused by sampling 
error or histological underdiagnosis of the primary punch biopsy. Two of the 3 mixed type BCCs 
were identified using a more extensive step-sectioning method, as described earlier. However, 
additional step sectioning is not able to detect mixed type BCCs as a result of sampling error of 
the punch biopsy location within the lesion. The usage of non-invasive diagnostic tools, such as 
the RCM, can reduce the risk of sampling error as it offers the possibility to visualise the entire 
lesion and distinguish different BCC subtypes.10,11 
Aim 2: To investigate the applicability of in vivo reflectance confocal 
microscopy in non-melanoma skin cancer
Non-melanoma skin cancer, predominantly comprising BCC and SCC, is the most common type 
of malignancy in the fair-skinned population. Moreover, its incidence and thereby health care 
costs, are rising.1 This emphasizes the importance of the appropriate diagnosis and treatment. 
Histological confirmation to establish the diagnosis is considered the gold standard. However, 
as stated above, punch biopsies obtained from skin lesions and histological examination of 
these biopsies are prone to sampling errors. To reduce the risk of sampling error and to make the 
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diagnosis more patient friendly and efficient, non-invasive diagnostic techniques can be used. 
In Chapter 3 we investigated the applicability of in vivo RCM to diagnose NMSC non-invasively. 
Early recognition of SCC is important, as it attributes to the majority of NMSC-related metastases 
and deaths.12 However, clinical differentiation between invasive SCC, SCC in situ, its precursor 
lesions and variants can be difficult. Chapter 3.1 describes the diagnostic and monitoring 
RCM features for entities within the continuum of AK and SCC. An extensive literature search 
revealed 25 eligible studies on AK (n=15), AC (n=1), EoQ (n=1), BD (n=7), SCC (n=8) and 
KA (n=2). Most studies were case series, followed by case-control studies, cohort studies and 
one case report. Overlapping RCM features for all these entities were scale, hyperkeratosis and 
atypical keratinocytes arranged in an atypical honeycomb pattern (mild atypia) or architectural 
disarray (severe atypia) in the stratum granulosum and stratum spinosum. Actinic keratosis and 
AC showed similar features including parakeratosis, poorly defined and irregular keratinocyte 
cell boundaries, exocytosis, dilated blood vessels and dermal solar elastosis. Bowens disease 
and EoQ also displayed (epi)dermal dendritic cells, whereas KA demonstrated round nucleated 
cells. Squamous cell carcinoma showed more extensive atypia in the spinous-granular layer, 
severe architectural disarray in the stratum granulosum and increased diameter of blood vessels 
compared to AK. Furthermore, nest-like structures can be found in the dermis in SCC. When 
using RCM as a monitoring tool after treatment, a decrease in epidermal atypia was observed 
in AK and AC. Overall, the range of sensitivity and specificity of RCM for the diagnosis of these 
entities was 79-100% and 78-100%. Unfortunately, a limited depth penetration in hyperkeratotic 
lesions imposes a major restriction for RCM evaluation. Careful curettage of the hyperkeratotic 
scale or pretreatment with keratinolytic agents can evade this problem.13 Moreover, the majority 
of the studies within this systematic review reached a moderate methodological quality (using 
the Strengthening the Reporting of Observational studies in Epidemiology criteria (STROBE)). 
This was mainly due to the lack of description of potential sources of bias, statistical methods 
and descriptive data. A randomised controlled trial of high methodological quality, comparing 
RCM with punch biopsy or surgical excision for clinical suspected lesions in this particular area, 
can contribute to determining the diagnostic accuracy.
In daily clinical practice, AKs are frequently diagnosed. However, their clinical appearance can 
be similar to SCCs. Therefore, it is important to distinguish AKs from invasive SCCs. In Chapter 
3.2 we report the use of RCM in differentiating between these two entities. The presence of 
architectural disarray in the stratum granulosum in combination with architectural disarray in the 
stratum spinosum and/or tumour nests in the dermis were the main RCM features to distinguish 
SCC from AK. This study also showed a poor to no interobserver agreement between an 
experienced and inexperienced RCM user. This illustrates the importance to learn to interpret the 
RCM images for AK and SCC specific features. Pellacani et al. showed a significant correlation 




observers.14A study on the learning curve of new RCM users in detecting specific RCM features 
will give more information on the time needed to invest in training in order to develop adequate 
education programmes. In addition, using the software available on the Vivascope systems 
(most widely used RCM device), it is possible to send the RCM images to experts in other 
centres for analysis and diagnosis. This contributes in the learning curve of beginning RCM 
users and increasing the number of centres that offer RCM as a non-invasive diagnostic method. 
Up until now, multiple studies have addressed the role of RCM in diagnosing BCC.10,11,15-22 It is 
postulated that RCM is more patient friendly due to its non-invasive character and more cost-
effective compared to the gold standard using histology. In Chapter 3.3  protocol for a prospective 
multicenter RCT is described which evaluates the non-inferiority of RCM to histopathology using 3 
mm punch biopsies in diagnosing BCC and its subtype. Furthermore, the quality of life, costs and 
quality adjusted life years will be evaluated using several questionnaires. A total of 329 patients 
with clinically suspicious BCC lesions and eligible for RCM imaging will be included. Initially, 3 
centers in the Netherlands consented in joining this study (Radboud university medical center, 
Nijmegen; Canisius-Wilhelmina hospital, Nijmegen; Rijnstate hospital, Arnhem). Thereafter, a 
fourth center joined the study (The Netherlands Cancer Institute, Amsterdam). Patients will be 
randomised into either the RCM or punch biopsy group. In case a BCC is diagnosed using RCM 
or punch biopsy, surgical excision will follow. This RCT started in January 2016 and is expect to 
finish at the end of 2018. 
Aim 3: To investigate the applicability of (video)dermoscopy in inflammatory 
skin diseases
Inflammatory lesions can be difficult to diagnose due to their heterogeneity, with risk of sampling 
an inappropriate site with relatively few morphological changes to establish a specific diagnosis. 
Using (video)dermoscopy, a large surface area can be examined under a high magnification, 
non-invasively. Videodermoscopy offers the ability to use a magnification up to 1000x, allowing 
visualisation of skin details that are invisible to the naked eye. Therefore, (video)dermoscopy can 
improve the clinical diagnosis without the need for invasive skin biopsies. 
In Chapter 4.1 current literature was systematically reviewed on the value of (video)dermoscopy 
in the diagnosis and monitoring of common inflammatory skin diseases. After an extensive 
literature search, 82 publications were included in the following categories: spongiotic dermatitis, 
psoriasiform dermatitis, nodular and diffuse dermatitis, palisading granulomatous dermatitis, 
sclerosing dermatitits, bullous dermatitis, alopecia and miscellaneous inflammatory and reactive 
disorders. Of the included studies, there was one RCT of moderate methodological quality. The 
remaining articles were cross-sectional studies (n=35), case reports (n=25), case series (n=15), 
cohort studies (n=4) and case-control studies (n=2) of moderate to low methodological quality. 
Each diagnosis showed distinctive (video)dermoscopic features, but also depicted features that 
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are similar to other ISD. Compared to dermoscopy, VD was able to detect specific vascular 
patterns in skin lesions and in the nail hyponychium of psoriasis patients that were not visible 
using dermoscopy. Furthermore, VD can contribute to standardisation of dermoscopic imaging 
by calibrating external factors resulting in more reproducible images. Subsequently, this can 
enhance the clinical judgment of skin lesions. VD can also aid in establishing a diagnosis more 
objectively, with the use of software programs that have a standardised pattern algorithm built 
in.23,24 Currently, the exact value of VD over conventional dermoscopy remains unclear. 
General discussion and future perspectives
This thesis shows various methods to reduce sampling errors. When using histopathology for 
the diagnosis of sBCCs, additional sectioning of the diagnostic punch biopsy, will diminish the 
risk of underdiagnosis due to sampling error. However, development of a more timesaving and 
cost-effective histopathological procedure is required prior to implementation. Furthermore, the 
use of non-invasive diagnostic tools, such as RCM and VD, offer the possibility to establish a 
diagnosis without the need to obtain invasive biopsies, while potentially reducing the risk of 
sampling error. 
In our opinion, the major clinical application of RCM lies in the field of dermato-oncology for 
both melanoma and NMSC. In the area of melanoma, Pellacani et al. showed that RCM is an 
useful technique when implemented in the standard care for melanoma in the university hospital 
of Modena and Reggio Emilia, Italy. It showed a significant reduction in the number of benign 
lesions excised when RCM was added as a diagnostic tool compared to the conventional 
medical care. Moreover, a reduction of the overall costs with 27% was observed.25 In the field of 
BCC, a RCT has recently been published that showed a higher treatment convenience in patients 
in the RCM group (diagnosing and subtyping BCC using RCM, followed by direct surgery) 
compared to group receiving standard care (histopathological evaluation of a punch biopsy 
prior to excision).26 The results of this study, combined with the future results of our ongoing 
RCT on the cost-effectiveness, will aid in incorporating RCM in the Dutch BCC guidelines and its 
implementation in the daily clinical practice.    
In this thesis, the use of in vivo RCM has been studied in NMSC in order to reduce the risk of 
sampling error. However, ex vivo RCM can also be a technique to reduce this risk. Ex vivo RCM 
enables visualisation of the skin layers in the horizontal view or vertical view, depending on how 
the tissue is fixated in the device. Using ex vivo RCM, an entire punch biopsy or excised lesion 
can be imaged for  the presence of a BCC and its subtype without the need for extensive tissue 
preparation, staining and sectioning. In order to resolve the limitation in laser penetration depth, 
both sides of the punch biopsy or excised tumour can be imaged. In addition, the biopsies or 




can be used to provide contrast in ex vivo RCM images in order to aid in the BCC diagnosis 
and subtyping.27 Therefore, ex vivo RCM can be an alternative to additional step-sectioning of 
a punch biopsy, when it comes to reducing the sampling error within a punch biopsy. Other 
clinical applications of in vivo and ex vivo RCM include BCC margin determination pre- and 
peroperatively.27-29 
In future, non-invasive diagnostic techniques will play a major role in dermatology. Though, more 
steps have to be taken to determine the value of the current available techniques, like RCM 
and VD, in the dermatological care. We have aimed to encourage others to use and further 
investigate the applicability of non-invasive imaging tools which will lead to implementation of 
these techniques in the daily clinical practice, resulting in more efficiency, more patient’s comfort 
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Het beschrijven van de morfologie van de huid speelt een belangrijke rol in de dermatologische 
diagnostiek. Tevens is het van belang om het effect van een behandeling te evalueren. Wanneer 
het niet mogelijk is om een diagnose te stellen op basis van het klinisch beeld, wordt veelal 
een punch biopt afgenomen. Een punch biopt wordt als de ‘gouden standaard’ gezien voor 
aanvullend onderzoek. Echter, een punch biopt is een invasieve diagnostische methode en 
kan daarmee leiden tot ontstekingen en littekenvorming van de huid. Daarnaast belemmert het 
afnemen van een huidbiopt de mogelijkheid om histopathologische veranderingen in de huid op 
dezelfde locatie te vervolgen in de loop van de tijd. Een veel voorkomend probleem is dat een 
punch biopt niet altijd representatief is voor de gehele laesie, waardoor een sampling error kan 
optreden. Een andere type sampling error ontstaat wanneer het meest agressieve of actieve 
deel van een punch biopt wordt gemist bij het histopathologisch onderzoek. Een sampling error 
kan resulteren in een aspecifieke diagnose of onder- of misdiagnose, hetgeen weer kan leiden 
tot inadequate behandelingen. Vanwege deze nadelen zijn in de afgelopen jaren nieuwe, niet-
invasieve beeldvormende technieken ontwikkeld. Deze technieken maken het mogelijk om de 
morfologie van de huid in detail te evalueren zonder dat er een punch biopt noodzakelijk is. Van 
de beschikbare beeldvormende technieken bieden de in vivo reflectie confocale microscoop 
(RCM) en de videodermatoscoop (VD) de mogelijkheid om te huid te onderzoeken met een 
hoge resolutie. Het doel van de onderzoeken, die staan beschreven in dit proefschrift, was om 
de huidige protocollen van het diagnostisch proces te optimaliseren en de morfologie van de 
huid te onderzoeken met behulp van geavanceerde beeldvormende technieken. 
Doel 1: Het onderzoeken van de sampling error in superficiële 
basaalcelcarcinomen en het klinisch effect hiervan
Het basaalcelcarcinoom is de meest voorkomende maligniteit in de Caucasische populatie.1 De 
histologische subtypering van het BCC is van belang, omdat de behandeling per subtype kan 
verschillen. Het superficiële BCC (sBCC) kan worden behandeld met niet-invasieve therapieën, 
terwijl agressieve BCCs (micronodulaire BCC (mnBCC) en infiltratieve BCC (iBCC)) met een 
grotere marge geëxcideerd worden dan laagrisico BCCs (nodulaire BCC (nBCC) en sBCC). De 
Europese richtlijn geeft de aanbeveling om een punch biopt af te nemen bij klinisch suspecte 
BCCs.2 Echter, in verschillende studies werd in 11% tot 39,1% van de gevallen bij excisie een 
agressievere BCC subtype gevonden, welke initieel gemist werd bij het punch biopt.3-5 Dit kan 
het resultaat zijn geweest van een sampling error van het punch biopt. In hoofdstuk 2.1 wordt 
de sampling error binnen een 3 mm punch biopt onderzocht. Alle onderzochte punch biopten 
hadden initieel de diagnose sBCC, gebaseerd op histopathologisch onderzoek van het punch 
biopt op 1 niveau. We vergeleken de nauwkeurigheid van het huidig histopathologisch proces 
(beoordeling van 1 niveau binnen een punch biopt) met een uitgebreid protocol (beoordeling 




BCC subtypes in 22,4%. Echter, het extra doorsnijden, kleuren en beoordelen van coupes 
op 4 additionele niveaus is tijdrovend, arbeidsintensief en duur in vergelijking met de huidige 
histopathologische methode. Daarom heeft een protocol dat minder uitgebreid is, maar alsnog 
een hoog aantal agressievere BCC subtypes detecteert, de voorkeur. Alternatieve protocollen zijn 
de evaluatie van 2 additionele niveaus (400 µm en 800 µm dieper dan de initiële H&E gekleurde 
coupes) of 1 additioneel niveau (800 µm dieper dan de initiële H&E gekleurde coupes). Dit 
levert een detectie van respectievelijk 20,7% en 19,8% op van andere BCC subtypes. Tevens 
kan een ander bestaand protocol als alternatief overwogen worden. In het Radboud universitair 
medisch centrum (Radboudumc) wordt doorgaans bij inflammatoire huidaandoeningen, die 
klinisch moeilijk te diagnosticeren zijn, een 4 mm punch biopt afgenomen. Deze biopten worden 
vervolgens centraal doorgesneden en op 2 niveaus bekeken. Het voordeel is dat in dit protocol 
een groter biopt wordt onderzocht en dat het voor pathologen minder tijdrovend is vergeleken 
met het protocol waarbij 5 niveaus wordt geëvalueerd. Echter, de 2 niveaus die bij de 4 mm 
punch biopten worden onderzocht, liggen zeer dicht bij elkaar. Hierdoor wordt  geen goed 
overzicht verkregen van het gehele punch biopt. Om deze reden lijkt deze methode niet geschikt. 
Daarnaast ontstaan BCCs vaak in het gelaat, waar het afnemen van een grotere punch biopt niet 
gewenst is vanwege het risico op een groter litteken. Opvallend in deze studie was, dat maar 
een klein aantal klinische recidieven en therapie falen werd gevonden. De follow up periode in 
dit onderzoek was korter dan een jaar, terwijl recidieven tot 3-4 jaar na behandeling nog kunnen 
ontstaan.6-8 Ons voornemen is om de follow up periode te verlengen om te onderzoeken of de 
detectie van een agressievere BCC subtype is geassocieerd met een hoger aantal recidieven. 
Een niet-chirurgische behandeling voor sBCC, met goede cosmetische resultaten, is 
methylaminolevulinaat fotodynamische therapie (MAL-PDT).9 De behandeling bestaat uit 
2 behandelsessies met een tussenpoos van 1 week. Eventueel kan dit, indien nodig, na 3 
maanden herhaald worden. Echter, dit protocol vereist minstens 2 ziekenhuis bezoeken. Dit is 
onpraktisch voor patiënten en kostbaar. In hoofdstuk 2.2 wordt een pilot studie beschreven 
waarin de klinische effectiviteit van 2 MAL-PDT behandelsessies op 1 dag voor de behandeling 
van sBCC werd onderzocht. De studie laat veelbelovende resultaten zien. Echter, bij 5 patiënten 
sloeg deze therapie onvoldoende aan. Bij verder onderzoek bleken 3 van deze 5 sBCCs toch 
een gemengd type BCC te betreffen. Dit kan of het gevolg zijn geweest van een sampling error of 
van histologische onderdiagnose van het punch biopt. Twee van de 3 gemengde BCCs werden 
geïdentificeerd met behulp van het intensievere protocol (evaluatie van 5 niveaus), zoals eerder 
beschreven. Echter, dit protocol is niet in staat om gemengde BCCs te detecteren die het gevolg 
zijn van een sampling error waarbij het minst agressieve deel van de laesie is gebiopteerd. In 
dergelijke gevallen kunnen niet-invasieve beeldvormende technieken, zoals RCM, het risico op 
sampling error verkleinen. RCM biedt de mogelijkheid om de gehele tumor in beeld te brengen 
en verschillende BCC subtypen te onderscheiden.10,11
192
CHAPTER 6
Doel 2: Het onderzoeken van de toepasbaarheid van in vivo reflectie 
confocale microscopie bij niet-melanoom huidkanker
Niet-melanoom huidkanker (NMSC), voornamelijk bestaande uit het BCC en plaveiselcelcarcinoom 
(PCC), is het meest voorkomende type kanker in de blanke populatie.1 Pathologisch onderzoek 
met punch biopten wordt gezien als de ‘gouden standaard’ om deze typen huidkanker 
te diagnosticeren. Echter, dit onderzoek is gevoelig voor sampling errors. Niet-invasieve 
diagnostische technieken, waarmee de gehele tumor kan worden onderzocht, kunnen het risico 
op sampling error verkleinen. Daarnaast zijn deze technieken patiënt vriendelijker vanwege het 
niet-invasieve karakter en de mogelijkheid om direct bij het eerste consult de diagnose te kunnen 
stellen. In hoofdstuk 3 wordt beschreven of RCM geschikt is om NMSC te diagnosticeren. 
Vroegtijdige detectie van PCC is van belang vanwege het risico op metastasering en de daarmee 
samenhangende mortaliteit.12 Echter, in de dagelijkse praktijk kan het klinisch onderscheid 
tussen invasief SCC, SCC in situ en de voorlopers en varianten van PCC soms lastig zijn. In 
hoofdstuk 3.1 worden zowel de diagnostische als monitoring kenmerken van RCM beschreven 
voor aandoeningen binnen het continuüm van actinische keratose (AK) en PCC. Een uitgebreid 
literatuuronderzoek leverde 25 studies op die in het systematic review werden geïncludeerd; AK 
(n=15), actinische cheilitis (AC) (n=1), erytroplasia van Queyrat (EoQ) (n=1), Morbus Bowen 
(BD) (n=7), SCC (n=8) en keratoacanthoom (KA) (n=2). Het merendeel van de studies waren 
case-series, gevolgd door case-control studies, cohort studies en een case-report. Overlappende 
RCM kenmerken voor alle aandoeningen binnen dit continuüm waren schilfering, hyperkeratose 
en atypische keratinocyten gerangschikt in een atypische honingraatpatroon (milde atypie) of 
een onregelmatige architectuur (ernstige atypie) in het stratum granulosum en stratum spinosum. 
Actinische keratose en AC lieten soortgelijke kenmerken zien met daarbij ook parakeratose, slecht 
afgrensbare en onregelmatige keratinocyten celgrenzen, exocytose, gedilateerde bloedvaten en 
dermale solaire elastose. Morbus Bowen en EoQ vertoonden ook (epi)dermale dendritische 
cellen, terwijl in KA ronde nucleaire cellen te zien waren. Plaveiselcelcarcinomen vertoonden 
meer uitgebreide keratinocyten atypie in de strata spinosum en granulosum, onregelmatige 
architectuur in het stratum granulosum en bloedvaten met een grotere diameter ten opzichte van 
AK. Tevens kunnen bij PCC nestachtige structuren worden gevonden in de dermis. In AK en AC 
werd middels RCM een vermindering van de epidermale atypie waargenomen na een periode 
van behandeling. In het algemeen was de diagnostische sensitiviteit en specificiteit van RCM 
tussen de 79-100% en 78-100%. Een limitatie van RCM is de beperkte penetratiediepte van de 
laser, met name in hyperkeratotische laesies. Curettage van de hyperkeratotische schilfering of 
voorbehandeling met keratinolytische middelen is dan aangewezen.13 Verder zijn het merendeel 
van de geïncludeerd studies in deze systematische review van matige methodologische kwaliteit 
(volgens de STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) 
criteria). Deze matige kwaliteit was voornamelijk het gevolg van gebrek aan omschrijving 




gerandomiseerde gecontroleerde studie (RCT) van hoge methodologische kwaliteit, waarbij 
RCM met een punch biopt of chirurgische excisie wordt vergeleken op dit gebied, zou kunnen 
bijdragen aan de diagnostische nauwkeurigheid van de RCM. 
In de dagelijkse praktijk presenteren patiënten zich vaak met AKs. Echter, het klinisch beeld van 
AK kan veel overeenkomsten vertonen met PCC. In hoofdstuk 3.2 hebben we daarom RCM 
kenmerken beschreven die onderscheid kunnen maken tussen AK en PCC. De aanwezigheid 
van een onregelmatige architectuur in het stratum granulosum gecombineerd met een 
onregelmatige architectuur in het stratum spinosum en/of dermaal gelokaliseerde tumornesten 
zijn de belangrijkste RCM kenmerken om onderscheid te maken tussen AK en PCC. Deze studie 
laat tevens zien dat er een slechte tot geen interobserver overeenkomst is tussen een ervaren 
en onervaren RCM gebruiker. Dit geeft aan hoe lastig het is voor een onervaren RCM gebruiker 
om de specifieke RCM kenmerken voor deze aandoeningen te interpreteren. Pellacani et al. 
rapporteerden een significante correlatie tussen het classificeren van keratinocyten atypie in AK 
middels RCM en histopathologie door ervaren geblindeerde RCM gebruikers.14 Een studie naar 
de leercurve van RCM gebruikers in het herkennen van specifieke RCM kenmerken zal meer 
informatie kunnen geven over hoeveel tijd geïnvesteerd moet worden aan training om zo adequate 
scholingsprogramma’s te ontwikkelen. Bovendien is het mogelijk om met de Vivascope software 
(meest gebruikte RCM apparaat) RCM beelden naar experts in andere centra te versturen voor 
analyse. Dit draagt bij aan de leercurve van een beginnende RCM gebruiker en hierdoor kan het 
aantal centra toenemen dat niet-invasieve RCM diagnostiek aanbiedt.
Meerdere studies hebben de diagnostische rol van RCM bij BCCs bestudeerd.10,11,15-22 RCM zou 
patiëntvriendelijker zijn vanwege het niet-invasieve karakter en de directe diagnosestelling, maar 
ook meer kosteneffectief zijn vergeleken met de huidige standaard methode voor diagnostiek 
middels histopathologisch onderzoek. In hoofdstuk 3.3 wordt het protocol beschreven voor 
een prospectief multicenter RCT waarmee onderzocht wordt of RCM minstens zo effectief is 
in het diagnosticeren van een BCC en het subtype, als de huidige diagnostische standaard, 
het histopathologisch onderzoek van een punch biopt. Tevens worden de kwaliteit van leven, 
aangepaste levensjaren en de kosten onderzocht met behulp van vragenlijsten. In totaal zullen 
329 patiënten met een klinisch suspecte BCC worden geïncludeerd. Aanvankelijk participeerde 
3 centra in Nederland (Radboud universiteit medisch centrum, Nijmegen; Canisius-Wilhelmina 
Ziekenhuis, Nijmegen; Rijnstate, Arnhem). Later nam ook het Antoni van Leeuwenhoek ziekenhuis 
in Amsterdam deel aan de studie. Patiënten worden gerandomiseerd voor RCM of voor een 
punch biopt. Indien een BCC wordt gediagnosticeerd, zal deze chirurgisch worden geëxcideerd. 




Doel 3: De toepasbaarheid van (video)dermatoscopie in inflammatoire 
huidaandoeningen
Inflammatoire aandoeningen zijn soms lastig te diagnosticeren vanwege hun heterogeniteit. Het 
risico bestaat dat een punch biopt wordt afgenomen van het deel van de laesie met relatief 
weinig morfologische veranderingen, waardoor het niet mogelijk is om een specifieke diagnose 
te stellen. Met behulp van (video)dermatoscopie kan een groot huidoppervlakte worden 
onderzocht onder hoge vergroting. Videodermatoscopie biedt de mogelijkheid om een het 
beeld tot 1000x te vergroten, waardoor details van de huid zichtbaar worden die niet met het 
blote oog kunnen worden waargenomen. Mogelijkerwijs zou (video)dermatoscopie de klinische 
diagnostiek verbeteren zonder de noodzaak van een invasief biopt.  
In hoofdstuk 4.1 wordt de rol van (video)dermatoscopie beschreven in het diagnosticeren 
en monitoren van algemene inflammatoire huidaandoeningen (ISD). In een uitgebreide 
literatuuronderzoek werden 82 publicaties geïncludeerd in de volgende categorieën: 
spongiotische dermatitis,psoriatiforme, perivasculaire dermatitis, nodulaire en diffuse dermatitis, 
palissaderende granulomateuze dermatitis, bulleuze dermatitis, alopecia en verscheidene 
inflammatoire en reactieve huidaandoeningen. Van alle geïncludeerd studies, was er één RCT 
van matige methodologische kwaliteit. Het resterend deel van de studies waren cross-sectionele 
studies (n=35), case reports (n=25), case series (n=15), cohort studies (n=4) en case-control 
studies (n=2) van matig tot laag methodologisch kwaliteit. Elke diagnose had onderscheidende 
(video)dermatoscopische kenmerken, maar had ook gemeenschappelijke kenmerken met 
andere inflammatoire huidaandoeningen. Met VD was het mogelijk om bij psoriasis patiënten 
specifieke vaatpatronen te detecteren in huidlaesies en de hyponychium van de nagel. Deze 
waren niet zichtbaar met de gewone dermatoscoop. Verder kan het gebruik van VD bijdragen aan 
het standaardiseren van dermatoscopische beelden omdat het kalibratie van externe factoren 
mogelijk maakt. Dit resulteert in reproduceerbare beelden, hetgeen een verbetering van het 
klinische oordeel van een laesie kan geven. Tevens zou met behulp van software programma’s, 
met een ingebouwd gestandaardiseerd  algoritme voor patronen,  behulpzaam kunnen zijn bij 
het stellen van de klinische diagnose.23,24 Echter, de meerwaarde van VD boven conventionele 
dermatoscopie is momenteel nog niet helemaal duidelijk. 
Algemene discussie en toekomstperspectieven
De onderzoeken in dit proefschrift beschrijven verschillende methoden om het risico op sampling 
error te verminderen. Indien histopathologisch onderzoek als diagnostisch middel wordt gebruikt, 
zou het extra doorsnijden van het diagnostisch biopt dit risico kunnen verkleinen. Dit kan bijvoorbeeld 
het geval zijn als de primaire diagnose sBCC is, waarbij de meeste behandelingsmogelijkheden 
niet-chirurgisch van aard zijn. Hierbij zou een sampling error de reden kunnen zijn waardoor een 




Echter, verdere ontwikkeling van een meer tijdbesparend en kosteneffectief histopathologisch 
onderzoeksprotocol wordt geadviseerd. Daarnaast kan het gebruik van niet-invasieve diagnostische 
technieken, zoals RCM en VD, het mogelijk maken om een diagnose te stellen zonder dat invasieve 
biopten noodzakelijk zijn en waarmee het risico op sampling error vermindert. 
Naar onze mening ligt de belangrijkste klinische toepassing van RCM op het gebied van dermato-
oncologie, voor zowel melanomen als NMSC. Op het gebied van melanomen, toonde Pellacani et 
al. aan dat RCM een bruikbare techniek is wanneer het wordt geïmplementeerd in de dagelijkse 
patiëntenzorg voor melanomen. Door toepassing van RCM werd een significante reductie van het 
aantal geëxcideerde benigne huidlaesies ten opzichte van één melanoom aangetoond. Tevens 
werd een daling in de kosten gezien van 27%.25 Op het gebied van NMSC, werd recent een RCT 
gepubliceerd die een hoger patiëntentevredenheid aantoonde in de RCM groep (diagnose en 
subtypering middels RCM, direct gevolgd door chirurgische excisie) vergeleken met de groep die de 
standaardzorg (histopathologische evaluatie van een punch biopt, gevolgd door excisie) ontving.26 
De uitkomsten van deze studie, gecombineerd met de resultaten van onze lopende studie over de 
kosteneffectiviteit, kunnen  bijdragen aan het opnemen van RCM als een diagnostisch middel in 
de Nederlandse BCC richtlijn en de implementatie ervan in de dagelijkse dermatologische praktijk. 
In dit proefschrift wordt de toepassing van in vivo RCM beschreven om het risico op sampling 
error te reduceren. Echter, ex vivo RCM zou hiervoor ook een geschikte methode kunnen zijn. Het 
is mogelijk om met ex vivo RCM de huidlagen in het horizontale of verticale vlak te visualiseren, 
afhankelijk van hoe het weefsel in het apparaat wordt gefixeerd. Middels ex vivo RCM kan een 
punch biopt of excisiepreparaat in zijn geheel onderzocht worden op de aanwezigheid van BCC 
nesten en subtypering zonder noodzaak tot uitgebreide weefselbewerking voor histopathologisch 
onderzoek. Beide zijden van het punch biopt of excisiepreparaat kunnen met ex vivo RCM 
onderzocht worden, of het weefsel kan worden doorgesneden. Op deze wijze is de beperkte 
penetratiediepte van RCM geen limitatie. Ex vivo RCM kan om deze reden tevens als alternatief 
dienen voor het uitgebreid histopathologisch protocol dat in dit proefschrift is beschreven. Verder 
kunnen bij ex vivo onderzoeken met RCM verschillende kleuringen gebruikt worden die kunnen 
bijdragen aan de verdere diagnostiek.27 Andere klinische toepassingen van RCM omvatten in vivo 
en ex vivo bepaling van de vrije marge voor en tijdens de chirurgische excisie van een BCC.27-29
In de toekomst zullen niet-invasieve diagnostische technieken een grote rol spelen in de 
dermatologie. Echter, er zullen meer stappen ondernomen moeten worden om de rol van de huidig 
beschikbare technieken, zoals RCM en VD, te bepalen binnen de dermatologische zorg. Middels 
dit proefschrift willen wij andere onderzoeksgroepen stimuleren om de toepassingen van niet-
invasieve beeldvormende technieken verder te onderzoeken en te ontwikkelen, hetgeen zal leiden 
tot de implementatie van deze technieken in de dagelijkse praktijk, resulterend in een efficiëntere 
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“Everything will be okay in the end. If it’s not okay, it is not the end.” (John Lennon)
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gewerkt en had dit niet kunnen doen zonder de hulp en steun van velen. Graag wil ik iedereen 
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blik, adviezen en bemoedigende woorden op zijn tijd. 
Dr. M. Peppelman, lieve Malou; jouw deur stond altijd open. Of het nu werk-gerelateerd was 
of niet, jij stond altijd voor mij klaar met een peptalk en een lijst met tips & tricks over hoe ik 
een probleem het beste aan kon pakken. Ik kon ook altijd op jou rekenen om mijn artikelen en 
presentaties tot in de details te controleren op dubbele spaties en typefouten. Mijn grote dank 
daarvoor!
Prof. dr. dr. P.C.M. van de Kerkhof, beste professor; bedankt voor de mogelijkheid om dit 
promotietraject op uw afdeling te mogen hebben doorlopen en uw enthousiasme voor mijn 
onderzoek. 
Dr. P.E.J. van Erp, beste Piet; bedankt voor jouw positiviteit, creativiteit en groot 
probleemoplossend vermogen. Wanneer ik het even niet meer wist, kon ik altijd bij jou 
aankloppen en stond je voor mij klaar. Dit heb ik enorm gewaardeerd. 
Dr. R.J.B. Driessen, beste Rieke; door jouw toetreding tot het RCM-team is mijn 
aandachtsgebied enorm verbreed. Ik heb van jou geleerd hoe ik met de juiste connecties een 
idee kan laten opbloeien tot een volledige studie. Bedankt voor jouw visie en begeleiding hierin 
en ik hoop dat ons nieuwe RCM-project mooie resultaten gaat opleveren in de toekomst! 
RCM-team, lieve Esther en Lisa; bedankt voor de mooie basis die jullie hebben gelegd voor het 
RCM-onderzoek, waarop ik met mijn eigen visie mocht voortborduren. Ik wens jullie heel veel 
succes met jullie verdere carrières. 
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om in zó een fijne club te mogen werken. Helaas kan ik jullie niet allemaal paranimf maken, 
maar één voor één zijn jullie er voor mij geweest en dat betekent enorm veel voor me! Ik wens 
jullie allemaal veel succes met jullie onderzoeken en verdere carrières. 
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RESEARCH DATA STEWARDSHIP AND ACCESSIBILITY
Research data stewardship and accessibility
The data management of the studies included in this thesis followed the guidelines for the 
handling of research data established by the Clinical Research Center Nijmegen (CRCN). 
The guidelines comply with the Dutch Personal Data Protection Act (De Wet Bescherming 
Persoonsgegevens, Wbp) and the Code of Proper Conduct (Code Goed Gedrag - FEDERA).
The data management was applied in the following way: 
1.  Case Report Forms (CRFs) for data collection were designed by the investigators and 
subsequently approved by the ethics committee Regio Arnhem-Nijmegen (Commissie 
Mensgebonden Onderzoek, CMO). Each CRF contains demographical information, code 
and research data of a single volunteer. CRFs were designed in a paper version. These 
CRFs were kept in a locked cabinet at the Dermatology department of Radboud university 
medical center. 
2.  The codelists were created in both a paper and electronic version. The paper version was 
kept in a locked cabinet at the Dermatology department of Radboud university medical 
center, in a location different from the one used for the paper CRFs. The electronic version 
was saved in a password-protected folder on a server of the Dermatology department. 
3.  At the end of the study and after publication, the paper CRFs will be sealed and kept in 
the locked cabinet at the Dermatology department of Radboud university medical center. 
The paper version of the codelists will be printed and the name of the principal investigator, 
signature and date will be placed on the documents. Afterwards, these documents will be 
scanned into an electronic version, which will be saved in a password-protected folder on a 
server of the Dermatology department. The electronic codelists will be locked. 
4.  At the end of the study and after publishing the data, the data and codelists on paper will 
be archived at the Dermatology department for a period of one year. Thereafter, they will be 
archived in an external paper archive. The locked electronic data sets and codelists will be 
saved on a password-protected folder on a server of the Dermatology department. 
5.  At any time during and after the studies, access to the CRFs and codelist was restricted to 







5-FU  5- Fluorouracil cream
AC  actinic cheilitis
ACD  allergic contact dermatitis 
AD  atopic dermatitis
AK  actinic keratosis
AM  alopecia mucinosa
BCC  basal cell carcinoma
BD  Bowen’s disease
CCCA   central centrifugal cicatricial alopecia
CHE  chronic hand eczema
CLE   chronic lupus erythematosus
CM  cutaneous mastocytosis
CS  cutaneous sarcoidosis
CU  common urticaria
DC  dissecting cellulitis
DLE   discoid lupus erythematosus
EoQ  erythroplasia of Queyrat
ER   erythematoteleangiectatic rosacea
FD  folliculitis decalvans
FFA  frontal fibrosing alopecia
GA  granuloma annulare
GP  guttate psoriasis
GF  granuloma faciale
GP  guttate psoriasis
H&E  hematoxylin and eosin
iBCC   infiltrative basal cell carcinoma
ICD  irritant contact dermatitis
ISD  inflammatory skin lesions
KA  keratoacanthoma
KIN   keratinocyte intraepithelial neoplasia
LE  lupus erythematosus
LP  lichen planus
LPP  lichen planopilaris
LS  lichen sclerosus
LSC  lichen simplex chronicus
LV  lupus vulgaris
MAL-PDT  methyl aminolevulinate photodynamic therapy
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mnBCC   micro-nodular basal cell carcinoma
nBCC   nodular basal cell carcinoma
NL  necrobiosis lipoidica
NMSC  non-melanoma skin cancer
NVC   nailfold videocapillaroscopy 
PALGA   Pathologisch Anatomisch Landelijk Geautomatiseerd Archief  
(registry of histo-and cytopathology in the Netherlands)
PCA  primary cicatricial alopecia
PD  polarised dermoscopy
PLC   pityriasis lichenoides chronic
PN  prurigo nodularis
PNCD   polarized light noncontact dermoscopy
PP  plaque psoriasis
PR  pityriasis rosea
PRP  pityriasis rubra pilaris
Radboudumc  Radboud university medical center
RCM   reflectance confocal microscopy
SB  stratum basale
sBCC   superficial basal cell carcinoma
SC  stratum corneum
SCC  squamous cell carcinoma
SD  seborrhoeic dermatitis
SDI   Standards for Dermatological Imaging
SG  stratum granulosum
SLE   systemic lupus erythematosus
SNFC   stereomicroscope nailfold capillaroscopy
SS  stratum spinosum
SSc  systemic sclerosis
STROBE   Strengthening the Reporting of Observational studies in Epidemiology 
TMEP   teleangiectasia macularis eruptiva perstans
UP  urticaria pigmentosa
VAS   Visual Analogue Scale score
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